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ABSTRACT	  	  It	  is	  well	  accepted	  that	  neuropeptides,	  together	  with	  cytokines,	  play	  an	  important	  role	  in	  osteoclastic	  activity	  and	  osteoclastogenesis	  associated	  with	  bone	  resorption	  observed	  in	  patients	   submitted	   to	   hip	   revision	   surgeries.	   Among	   the	   different	   neuropeptides,	  Neuropeptide	  Y	   (NPY)	   and	   Substance	  P	   (SP)	  were	   found	   to	   be	   expressed	   in	   bone	   and	  joint	  tissues	  and	  associated	  with	  some	  inflammatory	  processes	  in	  the	  joints.	  NPY	  system	  is	   still	   considered	   as	   a	   modulator	   in	   inflammatory	   diseases	   such	   as	   chronic	   arthritis,	  where	  increased	  amounts	  of	  NPY	  are	  found	  in	  the	  joints,	  being	  responsible	  for	  reactions	  such	  as	  joint	  pain	  and	  synovitis.	  	  This	   work	   aims	   to	   characterize	   NPY,	   SP	   and	   Pro-­‐inflammatory	   cytokines	   expression	  profile	   and	  distribution	   in	   the	   interface	  membrane	   that	   surrounds	   loose	   prosthesis	   of	  patients	   submitted	   to	   hip	   arthroplasties,	   in	   order	   to	   evaluate	   the	   impact	   of	   the	  neuropeptides	  in	  the	  modulation	  of	  the	  inflammatory	  response.	  	  We	  successfully	  established	  the	  protocol	  to	  collect	  and	  preserve	  sample	  tissues	  from	  hip	  arthroplasties,	  optimized	  the	  RNA	  extraction,	  PCR	  and	  immunohistochemistry	  protocols	  for	   the	   targeted	   neuropeptides	   and	   cytokines.	   NPY,	   SP	   and	   the	   pro-­‐inflammatory	  cytokines	   (IL-­‐6,	   TNF-­‐α	   and	   IL-­‐1β)	   profile	   were	   analyzed	   in	   tissues	   (Real	   Time-­‐PCR)	  retrieved	   from	   patients	   submitted	   to	   primary	   hip	   arthroplasty	   and	   total	   hip	   revision	  arthroplasty.	  	  NPY,	   IL-­‐6,	   IL-­‐1β,	  TNF-­‐α	  and	  SP	  genetic	  expression	  was	  detected	   in	  all	   samples.	  TNF-­‐α,	  IL-­‐1β	  and	  SP	  showed	  higher	  expression	  levels	  in	  primary	  arthroplasties	  when	  compared	  with	   revision	   arthroplasties.	  On	   the	   other	   hand,	  NPY	   and	   IL-­‐6	   have	  higher	   expression	  levels	   in	   revision	   arthroplasties.	   Immunohistochemical	   studies	   of	   the	   tissues	   showed	  that	   nerve	   fibers	   and	   NPY	   were	   localized	   mainly	   around	   blood	   vessels	   while	   CD68	  staining	  revealed	  a	  clear	  difference	   in	  the	  macrophages	  distribution	  and	  concentration	  between	   the	   two	   tissues.	   In	   primary	   arthroplasties	   the	   macrophages	   were	   less	  concentrated	   and	   arranged	   along	   synovial	  membrane	   in	   two	   to	   three	   cell	   layers	   thick	  while	  in	  revision	  arthroplasty	  they	  were	  evenly	  distributed	  in	  the	  tissue.	  	  In	   vitro	   studies	   using	   macrophages	   in	   the	   presence	   of	   cobalt	   nanoparticles	   showed	  expression	  of	  TNF-­‐α,	  IL-­‐1β,	  NPY	  and	  Y1R.	  NPY	  and	  Y1R	  release	  was	  also	  detected.	  Overall	   our	   results	   suggest	   a	   role	   of	   NPY	   system	   in	   the	   inflammatory	   process	   that	   is	  triggered	  by	  wear	  debris	  but	  more	  samples	  and	  further	  studies	  are	  needed	  for	  a	  better	  comprehension	   of	   the	   influence	   of	   peripheral	   nervous	   system	   in	   the	   inflammatory	  process	   that	   leads	   to	   the	   failure	   of	   the	   hip	   prostheses.	   This	   is	   a	   promising	   field	   of	  research	   that	  may	   lead	   to	   the	   identification	  of	  new	  therapeutic	   targets	   to	   treat	  and/or	  prevent	  particle	  induced	  osteolysis.	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RESUMO	  	  Sabe-­‐se	   que	   neuropéptidos,	   em	   conjunto	   com	   citocinas,	   desempenham	   um	   papel	  importante	   na	   actividade	   osteoclástica	   que	   se	   encontra	   associada	   com	   a	   reabsorção	  óssea	  observada	  em	  pacientes	  submetidos	  a	  cirurgia	  de	  revisão	  da	  anca.	  Entre	  os	  vários	  neuropéptidos,	  o	  Neuropeptídeo	  Y	   (NPY)	  e	  Substância	  P	   (SP),	   são	  expressos	  no	  osso	  e	  tecidos	  articulares,	  sendo	  associados	  a	  alguns	  processos	  inflamatórios	  das	  articulações.	  O	  sistema	  NPY	  é	  considerado	  como	  um	  modulador	  em	  doenças	  inflamatórias	  tais	  como	  a	  artrite	  crónica,	  onde	  são	  encontrados	  níveis	  elevados	  de	  NPY	  nas	  articulações.	  	  Este	  trabalho	  pretende,	  assim,	  caracterizar	  o	  perfil	  de	  expressão	  e	  distribuição	  do	  NPY,	  SP	   e	   citocinas	   pró-­‐inflamatórias	   na	   membrana	   adjacente	   à	   prótese	   de	   doentes	  submetidos	  a	  artroplastia	  da	  anca,	  de	  forma	  a	  avaliar	  o	  impacto	  dos	  neuropeptídeos	  na	  modulação	  da	  resposta	  inflamatória.	  O	  protocolo	  para	  recolher	  e	  preservar	  os	  tecidos	  das	  amostras	  de	  artroplastias	  da	  anca	  foi	   otimizado,	   assim	   como	   o	   protocolo	   de	   extração	   de	   RNA,	   PCR	   e	   protocolos	   de	  imunohistoquímica	  para	  os	  neuropeptídeos	  e	  citocinas	  específicas.	  O	  perfil	  do	  NPY,	  SP	  e	  citoquinas	  pró-­‐inflamatórias	  (IL-­‐6,	  TNF-­‐α	  e	  IL-­‐1β)	  foi	  analisado	  nos	  tecidos	  (Real-­‐Time	  PCR)	   recolhidos	   de	   doentes	   submetidos	   a	   artroplastias	   primárias	   da	   anca	   e	   a	  artroplastias	  de	  revisão	  da	  anca.	  A	   expressão	   de	   NPY,	   IL-­‐6,	   IL-­‐1β,	   TNF-­‐α	   e	   SP	   foi	   verificada	   em	   todas	   as	   amostras.	   No	  entanto,	   dado	   a	   amostragem	   em	   estudo	   ser	   pequena	   não	   foi	   encontrada	   nenhuma	  relação	   entre	   estes	   mediadores.	   Os	   estudos	   de	   imunohistoquímica	  mostraram	   que	   as	  fibras	   nervosas	   (NF200)	   e	   NPY	   são	   localizadas	   principalmente	   na	   periferia	   dos	   vasos	  sanguíneos,	   e	   a	   coloração	   CD68	   revelou	   uma	   clara	   diferença	   na	   distribuição	   e	  concentração	  dos	  macrófagos	  entre	  os	  dois	  grupos	  de	  doentes.	  Na	  artroplastia	  primária	  verificou-­‐se	   que	   os	   macrófagos	   são	   menos	   abundantes	   e	   são	   dispostos	   ao	   longo	   da	  membrana	   sinovial,	   formando	   uma	   membrana	   de	   duas	   a	   três	   camadas	   de	   células	   de	  espessura,	   enquanto	   que	   na	   artroplastia	   de	   revisão	   estes	   foram	   distribuídos	  uniformemente	  no	  tecido	  e	  encontram-­‐se	  em	  maior	  quantidade.	  Estudos	  in	  vitro	  foram	  realizados,	  utilizando	  macrófagos	  na	  presença	  de	  nanopartículas	  de	  cobalto.	  Estes	  expressaram	  TNF-­‐α,	  IL-­‐1β,	  NPY	  e	  altas	  concentrações	  do	  receptor	  Y1.	  	  Em	  geral,	   os	  nossos	   resultados	   sugerem	  um	  papel	  do	   sistema	  NPY,	  nomeadamente	  do	  receptor	  Y1,	  no	  processo	   inflamatório	  que	  é	  desencadeado	  por	  partículas	  de	  desgaste.	  No	   entanto,	   mais	   amostras	   e	   estudos	   são	   necessários	   para	   complementar	   o	   estudo	   e	  melhor	   compreender	   a	   influência	   do	   sistema	   nervoso	   periférico	   no	   processo	  inflamatório	  que	  leva	  à	  falha	  da	  prótese	  da	  anca.	  
	   vi	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  nanomolar	  NPs-­‐	  nanoparticles	  NPY	  -­‐	  Neuropeptide	  Y	  	  NSAIDs	  -­‐	  Non-­‐steroidal	  anti-­‐inflammatory	  drugs	  OA	  –	  Osteoarthritis	  PACAP	  -­‐	  Pituitary	  adenylate	  cyclase	  activating	  peptides	  	  PBS	  –	  phosphate	  buffered	  saline	  PGP	  9.5	  –	  protein	  gene	  product	  9.5	  PMA	  –	  phorbol-­‐miristate-­‐acetate	  PNS	  -­‐	  Peripheral	  nervous	  system	  P/S	  –	  penicillin/streptomycin	  RA	  –	  Rheumatoid	  arthritis	  RANKL	  -­‐	  Receptor	  activator	  of	  nuclear	  factor	  kappa-­‐B	  ligand	  RNA	  –	  ribonucleic	  acid	  rpm	  –	  revolutions	  per	  minute	  	  RT	  –	  room	  temperature	  RT-­‐PCR	  –	  reverse	  transcription	  polymerase	  chain	  reaction	  sec	  –	  second	  	  SP	  –	  Substance	  P	  THA	  –	  Total	  hip	  arthroplasty	  THR	  –	  Total	  hip	  replacement	  TJA	  –	  Total	  joint	  arthroplasty	  	  TNF-­‐α	  -­‐	  Tumour	  necrosis	  factor-­‐α	  VIP	  -­‐	  Vasoactive	  intestinal	  polypeptide	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A.	  The	  Hip	  Joint	  	  
1.	   Hip	   Joint	   Characterization:	   Composition,	   Morphology	   and	  







Figure	  1.	  Normal	  Hip	  Joint.	  From	  http://www.hss.edu/hip-­‐pain-­‐center-­‐hip-­‐conditions.asp	  	  The	  hip	  joint	  is	  classified	  as	  a	  synovial	  joint.	  Synovial	  joints	  have	  a	  variety	  of	  shapes	  and	  allow	  numerous	  types	  of	  movements.	  The	  most	  unique	  characteristic	  of	  a	  synovial	  joint	  is	   the	  presence	  of	  a	  space	  called	  synovial	  cavity	  between	  the	  articulating	  bones,	  which	  allows	  joints	  to	  move	  freely	  [5].	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A	   synovial	   joint	   comprises	   both	   hard	   and	   soft	   tissues	   [6].	   They	   are	   characterized	   by	  having:	  a	  joint	  cavity;	  a	  lubricated	  articular	  cartilage	  covering	  joint	  surfaces;	  a	  capsule	  of	  fibrous	  (ligamentous)	  tissue;	  and	  a	   lining	  of	  synovial	  membrane	  with	  synovial	   fluid	  [2,	  7].	  The	  surfaces	  of	  the	  bones	  that	  form	  the	  hip	  joint	  do	  not	  come	  in	  direct	  contact	  with	  each	  other	   because	   they	   are	   covered	   by	   articular	   cartilage	   that,	   frequently,	   is	   hyaline	  cartilage.	   This	   hyaline	   cartilage	   is	   a	   smooth	   and	   slippery	   surface	   that	   follows	   the	  contours	  of	  the	  bone,	  minimizes	  friction	  between	  bones	  during	  movement	  and	  helps	  to	  absorb	  shock	  by	  widely	  distributing	  the	  joint	  loads.	  It	  is	  nourished	  by	  synovial	  fluid	  and	  by	   diffusion	   from	   small	   blood	   vessels	   that	   supply	   the	   bone	   [4,	   5,	   7].	   Damage	   to	   the	  articular	  cartilage	  can	  reduce	  movements	  of	  the	  surfaces	  over	  each	  other	  and	  limit	  the	  range	  of	  motion	  [4].	  In	   a	   synovial	   joint,	   the	   interior	   of	   the	   joint	   plate	   disappears	   to	   be	   replaced	   by	   a	   joint	  cavity	   surrounded	   by	   a	   sleeve	   of	   fibrous	   tissue,	   the	   joint	   capsule,	   which	   encloses	   the	  synovial	   cavity,	   unites	   the	   articulating	   bones	   and	   becomes	   continuous	   with	   the	  periosteum,	  as	  illustrated	  in	  Figure	  1.2.	  [5,	  7].	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Figure	   2.	   A	   cross-­‐sectional	   diagram	   through	   a	   synovial	   joint,	   From	  
http://virtual.yosemite.cc.ca.us/rdroual/	  
	  	  The	   articular	   capsule	   is	   composed	   of	   two	   layers,	   the	   external	   fibrous	   capsule	   and	   the	  internal	   synovial	  membrane.	   	  The	   fibrous	   layer	   consists	   in	  dense,	   irregular	   connective	  tissue	   that	   is	   flexible	   enough	   to	   allow	   movement	   and	   strong	   enough	   to	   prevent	  dislocation	   of	   the	   bones.	   Blood	   vessels	   and	   nerves	   penetrate	   this	   layer,	   and	   in	   some	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joints	   the	   capsule	   may	   be	   thickened	   with	   separate	   thick	   connective	   tissue	   called	  ligaments	  [4,	  5].	  Innervation	  of	  the	  hip	  joint	  varies	  from	  individual	  to	  individual	  and	  may	  include	  the	  femoral	  nerve,	  the	  obturator	  nerve	  and	  the	  sciatic	  nerve	  [3,	  8].	  The	  inner	  layer	  of	  the	  articular	  capsule	  is	  lined	  with	  a	  delicate	  membrane,	  the	  synovial	  membrane	   that	   is	   composed	   of	   connective	   tissue	   containing	   blood	   vessels	   and	   nerve	  fibers,	  and	  forms	  a	  closed	  sac	  called	  synovial	  cavity.	  At	  many	  synovial	  joints,	  the	  synovial	  membrane	  includes	  accumulations	  of	  adipose	  tissue,	  called	  fat	  pads	  [4,	  7].	  The	   synovial	   membrane	   secretes	   synovial	   fluid,	   which	   forms	   a	   thin	   film	   over	   the	  surfaces	  within	  the	  articular	  capsule.	  The	  synovial	   fluid	   is	  viscous,	   thick	  and	  clear,	  and	  consists	  of	  an	  ultrafiltrate	  of	  plasma,	  containing	   trace	  amounts	  of	  nonplasma	  proteins,	  lipids,	   hyaluronic	   acid,	   and	   high-­‐molecular-­‐weight	   proteins	   such	   as	   fibrinogen,	   α2-­‐microglobulin,	   β2-­‐macroglobulin	   and	   β1-­‐lipoprotein,	   as	  well	   as	   proteoglycans	   secreted	  by	   the	   fibroblasts	   of	   the	   synovial	  membrane	   [4,	   5,	   9].	   Functionally,	   the	   synovial	   fluid	  serves	  to:	  1)	   lubricate	  and	  reduce	  friction	  between	  the	  moving	  surfaces	  of	  the	  joint;	  2)	  supply	   nutrients	   and	   remove	  metabolic	  wastes	   from	   the	   articular	   cartilage;	   3)	   absorb	  shock,	   since	   fluid	  helps	   to	  distribute	   the	  pressure	  across	   the	  articular	  surfaces;	  and	  4)	  defense	  –	  the	  synovial	  fluid	  contains	  phagocytic	  cells	  that	  remove	  debris	  and	  prevent	  the	  entry	  of	  microorganisms	  [4,	  5].	  	  
	  
1.1.	  Synovial	  Membrane	  
The	  synovial	  membrane	  lines	  the	  capsule	  and	  is	  attached	  to	  the	  margins	  of	  the	  articular	  surfaces.	  This	  membrane	   is	   constituted	  by	   a	   fibrilar	   interstitial	  matrix	  of	   collagen	  and	  glycosaminoglycans	  containing	  synovial	  cells,	  one	  to	  three	  cell	  layers	  thick.	  Contrary	  to	  normal	  epithelial	  cells,	  synovial	  cells	  do	  not	  have	  desmosomal	  junctions,	  and	  there	  is	  no	  basement	   membrane	   between	   the	   synovial	   lining	   and	   subsynovial	   tissue.	   Synovial	  tissues	  have	  also	  nerves,	  lymphatics,	  and	  capillaries	  with	  endothelial	  cells	  [9].	  Considering	  the	  properties	  of	  the	  tissue,	  synovial	  membrane	  is	  soft,	  thin,	  pale	  and	  semi-­‐transparent.	   It	  can	  distend	  by	  the	  effusion	  of	   fluid	  and	  is	  capable	  of	  a	  slow	  contraction	  when	  absorption	  takes	  place	  [10].	  	  Synovium	   and	   cartilage	   are	   originated	   from	   a	   common	   source	   of	   progenitor	   cells	   and	  synovial	  tissue	  expresses	  a	  variety	  of	  cartilage	  specific	  markers	  [11].	  In	   a	   normal	   situation	   it	   represents	   an	   irregular	   and	   thin	   membrane;	   however,	   in	   a	  situation	   of	   an	   acute	   inflammation	   the	   appearance	   changes	   considerably	   and	   it	   turns	  into	  a	  fibrous	  membrane	  (Figure	  3.)	  [12].	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Figure	  3.	  Synovial	  membrane	  in	  total	  hip	  arthroplasty	  implants.	  bv,	  blood	  vessel;	  sl,	  synovial	  lining.	  
Arrows	   represent	  macrophages	   and	   arrowheads	   represent	   fibroblast-­‐like	   cells.	   Scale	   bars	   50	  μm.	  
Adapted	  from	  [13].	  
	  
	  
2.	  Hip	  Joint	  Diseases	  
	   2.1.	  Snapping	  Hip	  Syndrome	  
Snapping	   hip	   syndrome	   is	   a	   well-­‐recognized	   complex	   symptom,	   characterized	   by	   an	  audible	   or	   palpable	   snap	   occurring	   around	   the	   hip	   during	   motion,	   and	   it	   is	   often	  associated	  with	  pain	  that	  is	  aggravated	  by	  sitting	  [14-­‐16].	  	  Snapping	  hip	  syndrome	  occurs	  in	  5	  to	  10%	  of	  the	  general	  population,	  and	  teenagers	  and	  young	   adults	   are	   typically	   affected	   [15].	   This	   inflammation	   is	   usually	   associated	  with	  injury	   and	   it	   is	   not	   associated	   with	   any	   preferring	   occupation	   or	   activity;	   however	   a	  higher	   incidence	   has	   been	   reported	   in	   people	   participating	   in	   activities	   requiring	  extreme	  hip	  movements	  (dancers,	  soccer	  players	  and	  runners).	  The	  identification	  of	  the	  underlying	  anatomical	  defect	   is	  often	  very	  challenging	  and	  radiological	   investigation	  is	  mandatory	  [14,	  15].	  Snapping	   hip	   syndrome	   has	   been	   classified	   into	   internal,	   external	   and	   intra-­‐articular	  types.	   The	   external	   type	   is	   the	   most	   common,	   with	   only	   a	   few	   cases	   having	   been	  reported	  in	  the	  pediatric	  population	  [16].	  	  	  	  	  
Septic loosening
Purulent synovial membrane-like samples were
more heterogeneous in nature. Large areas of necro-
sis and fibrosis were seen in some samples, whereas
other samples consisted of loose connective tissue
covered by synovial lining, with an intense inflam-
matory reaction containing heterogeneous cell popu-
lations. Large CD68- and CD163-positive monocyte/
macrophage infiltrated areas (Fig. 2, panel A) and
occasionally also foreign body giant cells as well as
granulomas were seen (Fig. 2, panel G). Some phag-
ocytosed wear particles were detected. Neutrophils
formed considerable infiltrates in some areas (Fig. 2,
panel H). High numbers of scattered and nodular
CD3-positive T lymphocytes were seen (Fig. 2, panel
D). Also nodular CD20-positive B-lymphocyte infil-
trates were seen (Fig. 2, panel E). Some of the B lym-
phocytes had been activated to CD138-positive
plasma cells with classical cytological features, often
Figure 1. Toll-like receptors (TLRs) and resident and immigrant cells in osteoarthritis and aseptic loosening of total hip
replacement implants. (A) TLR4 staining of osteoarthritic synovial membrane consisting of mildly inflamed and edematic
loose connective tissue. Some of the fibroblast-like cells (arrowheads) and monocyte/macrophage-like cells (arrows) are
TLR4 positive. Note the presence of TLR4 in the vascular endothelium. (B) TLR9 staining of osteoarthritic synovial lining.
In addition to vascular endothelium and stromal fibroblast (arrowheads) and monocyte/macrophage-like cells (arrow)
note the intensive TLR9 staining of the synovial lining cells. (C) CD68 staining of aseptic synovial membrane-like tissue
characterized by massive infiltrates of macrophages and the presence of foreign body giant cells (asterisks). (D) TLR4
staining of aseptic synovial membrane-like tissue. This consecutive section demonstrates that CD68-positive macrophages
and giant cells (asterisks) are also TLR4 positive. (E) CD3 staining of aseptic synovial membrane-like tissue. Few scattered
T lymphocytes (arrow) are seen among lightly showing but identifiable monocyte/macrophage infiltrates. No CD20-posi-
tive B lymphocytes could be detected in aseptic interface (data not shown). (F) HSP47 staining of aseptic synovial mem-
brane-like tissue. Along with lymphocytes, also fibroblasts (arrowheads) are seen between monocyte/macrophages. Immu-
noperoxidase staining counterstained with hematoxylin. Original magnification 4003. Scale bars 50 lm. bv, blood vessel;
ma, macrophage infiltration; sl, synovial lining.
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2.2.	  Bursitis	  
Bursitis	   is	   a	   common	   condition	   secondary	   to	   inflammation	   of	   one	   of	   the	   three	  major	  bursae	   in	   the	   hip:	   the	   trochanteric	   bursa,	   the	   iliopsoas	   bursa,	   and	   the	   ischiogluteal	  bursa.	  Since	  bursae	  are	  lined	  by	  the	  synovial	  tissue,	  bursitis	  also	  can	  occur	  with	  systemic	  disease,	  leading	  to	  synovitis	  [14].	  The	  main	  complications	  are	  local	  swelling	  and	  pain,	  but	  communication	  of	  the	  inflamed	  bursa	  with	  the	  joint	  can	  damage	  cartilage	  and	  trigger	  bone	  destruction	  [17].	  	  	  
2.3.	  Arthritis	  
Osteoarthritis	   (OA)	   is	   one	   of	   the	   most	   common	   diseases	   affecting	   the	   adult	   hip.	   This	  condition	   is	   often	   secondary	   to	   an	   underlying	   abnormality	   of	   the	   hip,	   such	   as	  developmental	  dysplasia.	   In	  some	  cases,	  however,	   there	   is	  no	   identifiable	  cause	  and	   in	  these	  situations	  the	  osteoarthritis	  is	  considered	  primary	  or	  idiopathic	  [14].	  	  It	   is	   a	   slowly	   developing	   disorder,	   characterized	   by	   non-­‐uniform	   degeneration	   of	  articular	   cartilage	   and	   reparative	   formation	   of	   new	   bone	   (Figure	   4),	  which	   results	   in	  stiffness	   and	   pain	   of	   the	   affected	   joint	   and	   a	   lack	   of	   elasticity	   in	   the	   new	   bone	  which	  results	  in	  tiny	  fractures	  [18,	  19].	  Consequently,	  motion	  in	  the	  hip	  becomes	  progressively	  restricted	  by	  painful	   synovitis	   and	  muscle	   spasm	  and	  by	   secondary	   tissue	   contracture	  [14].	   In	  a	  more	  advanced	  stage	  of	   the	  disease,	  bearing	  cartilage	  and	   the	  bone	  under	   it	  develop	   fissures	   through	  which	   the	   lubricating	   fluid	   is	   forced	   into	   the	  marrow	   of	   the	  bone	  resulting	  in	  loss	  of	  joints	  congruity	  and	  osteophyte	  formation	  [18].	  The	  bones	  get	  deformed,	   and	   even	   minor	   movements	   will	   cause	   friction	   between	   the	   ball	   and	   the	  socket	  of	  the	  hip,	  causing	  severe	  pain	  [20].	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Figure	   4.	   In	   the	   healthy	   joint	   (A)	   the	   thin	   synovial	  membrane	   lines	   the	   joint.	   In	   arthritis	   (B)	   the	  
synovial	  membrane	  becomes	  thicker	  and	  infiltrated	  by	  chronic	  inflammatory	  cells,	  developing	  into	  
'pannus',	  which	  migrates	  onto	  and	  into	  the	  articular	  cartilage	  and	  underlying	  bone.	  From	  [21]	  
	  
2.4.	  Avascular	  Necrosis	  
Avascular	  necrosis	   is	   caused	  by	   lack	  of	  blood	  supply	   into	   the	  bone,	   leading	   to	  osseous	  cell	   death	   and	   it	   is	   responsible	   for	   5%	   to	   12%	   of	   total	   hip	   replacements.	   The	   most	  commonly	   affected	   site	   is	   the	   femoral	   head	   and	   patients	   usually	   possess	   pain	   that	  usually	  develops	  progressively	   [20,	  22,	  23].	   If	  avascular	  necrosis	  progresses,	  bone	  and	  the	  surrounding	  joint	  surface	  may	  collapse	  causing	  increase	  in	  pain	  [20].	  Avascular	  necrosis	  of	  the	  femoral	  head	  is	  well	  recognized	  in	  association	  with	  fractures	  of	  the	  femoral	  neck	  and	  dislocations,	  and	  usually	  affects	  patients	  in	  the	  second,	  third	  and	  fourth	  decades	  of	  life	  [14,	  23].	  Continuous	  compression	  has	  been	  implicated	  as	  a	  cause	  for	  avascular	  necrosis.	  	  The	  pathologic	   change	   associated	  with	   the	   early	  phase	  of	   this	   disorder	   is	   a	   segmental	  necrosis	   of	   the	   femoral	   head,	   in	   which	   the	   overlying	   articular	   cartilage	   is	   unaffected.	  Afterwards,	   there	   is	   reparative	   tissue	   ingrowth	   with	   resorption	   of	   necrotic	   bone,	  complemented	  by	  formation	  of	  new	  bone	  on	  necrotic	  trabeculae.	  Therefore,	  the	  area	  of	  segmental	  necrosis	  deteriorates	  with	   resorption	  and	  a	   subchondral	   fracture	   can	  occur	  [14].	  The	   best	   alternative	   requires	   preservation	   of	   the	   femoral	   head	   or	   at	   least	   to	   delay	   its	  collapse	  or	  the	  onset	  of	  degenerative	  changes	  [23].	  	  
A	   B	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2.5.	  Fractures	  and	  dislocations	  
Stress	   fractures	   of	   the	   femur	   and	   the	   pelvis	   are	   not	   usual,	   but	   are	   a	   source	   of	   great	  controversial	   in	  diagnosis.	  A	  stress	  fracture	  is	  generally	  defined	  by	  a	  continuous	  stress	  below	   the	   failure	   levels	   of	   bone	   in	   a	   time	   period	   inadequate	   to	   allow	   for	   bone	  remodeling.	  Femoral	  stress	  fractures	  are	  not	  as	  common	  as	  stress	  fractures	  involving	  the	  pelvis	  but,	  if	   not	   recognized	   and	   treated	   appropriately,	   it	   may	   lead	   to	   fracture	   displacement	   or	  avascular	   necrosis	   of	   the	   femoral	   head.	   There	   are	   two	   types	   of	   femoral	   neck	   stress	  fractures:	   transcervical	   (distraction)	   and	   compression.	   A	   transcervical	   fracture	   is	   a	  superior	  transverse	  fracture	  involving	  the	  superior	  portion	  of	  the	  femoral	  neck.	  Internal	  fixation	   is	   the	  most	   recommended	   treatment	   and	   can	   cause	   associated	   complications	  such	  as	  displacement.	  Compression	   fractures	  are	   seen	  on	   the	   inferior	  medial	   aspect	  of	   the	   femoral	  neck	  and	  are	   frequently	   treated	   with	   nonweight-­‐bearing	   status	   until	   there	   is	   radiographic	  evidence	  of	  callus	  and	  healing	  [14].	  	   	  
2.6.	  Tumors	  
Hip	   or	   pelvic	   pain	   that	   persists	   for	   a	   long	   period	   of	   time	   following	   an	   apparently	  insignificant	  injury	  must	  be	  evaluated	  for	  the	  possibility	  of	  a	  pathologic	  lesion.	  	  Common	   pathologic	   lesions	   to	   the	   hip	   and	   pelvis	   include	   benign	   lesions	   such	   as	  unicameral	   bone	   cyst,	   osteoid	   osteoma,	   osteochondroma,	   or	   fibrous	   dysplasia;	  malignant	   neoplasm	   such	   as	   Ewing’s	   sarcoma	   and	   osteogenic	   sarcoma;	   and	   systemic	  endocrinopathies	  as	  hypothyroidism	  and	  renal	  ostodystrophy	  [14].	  	  	  
3.	  Hip	  Arthroplasty	  
	   3.1.	  Primary	  Artroplasty	  
Primary	   arthoplasty	   is	   the	   replacement	   of	   both	   articulating	   surfaces	   of	   a	   degenerated	  hip	  joint.	  Total	  hip	  arthroplasty	  or	  primary	  arthroplasty	  is	  the	  most	  effective	  treatment	  to	   improve	  quality	   of	   life	   to	  patients	  with	   serious	  hip	  disorders,	   especially	   in	  patients	  with	  OA	  [24-­‐27].	  Primary	  arthroplasty	  has	  been	  shown	  to	  improve	  patients’	   functional	  abilities,	   relieve	   pain	   and	   increase	   productivity,	   improving	   life	   quality	   of	   patients	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suffering	  from	  a	  severe,	  disabling	  hip	  disease	  and	  decreasing	  the	  reoperation	  rates	  [25,	  28-­‐31].	  It	   is	  not	  clear	   the	  reasons	  why	  patients	  do	  not	   improve	   in	   the	  same	  degree,	   leading	   to	  the	  need	  of	  consistent	  predictors	  of	  outcome	  after	  hip	  surgery	  [24].	  	  Primary	  arthroplasty	  was	  implemented	  in	  the	  60s	  and	  it	  is	  clear	  the	  improvement	  in	  the	  implant	   designs	   since	   then,	   that	   is	   promoting	  better	   long-­‐term	   clinical	   outcomes	   [32].	  Although	   its	   improvement,	   there	   are	   some	   complications	   with	   implants	   such	   as	  dislocations,	   infections,	   fractures	   and	   periprosthetic	   osteolysis	   caused	   by	  wear	   debris	  leading	  to	  a	  need	  of	  revision	  arthroplasty	  [30].	  	  
	  
3.2.	  Revision	  Arthroplasty	  
Revision	  arthoplasty	  consists	   in	   the	  replacement	  of	   the	  prostheses	   that	  was	   implanted	  in	  primary	  arthoplasty	  surgery.	  	  Osteolysis	   caused	  by	   cellular	   reactions	   to	  wear	  debris	   is	   a	  huge	  problem	   in	   long-­‐term	  implant	   survival.	   [33]	   Also,	   a	   miscalculation	   in	   the	   re-­‐establishment	   of	   the	   normal	  anatomy	   at	   primary	   arthoplasties	   is	   associated	   with	   frequent	   and	   higher	   rates	   of	  dislocation,	  muscle	  weakness,	  leg-­‐length	  discrepancy	  and	  early	  loosening	  of	  the	  implant	  [34].	  Another	   aspect	   to	   have	   in	   consideration	   at	   the	   time	   of	   primary	   arthroplasty	   is	   the	  impact	  of	  comorbidities	  such	  as	  age	  and	  weight	  [35].	  In	  order	  to	  improve	  outcomes	  after	  total	   hip	   replacement	   (THR)	   or	   revision	   arthroplasty	   it	   is	   necessary	   to	   identify	   risk	  factors	   that	   can	   predict	   postoperative	   complications,	   since	   revision	   arthroplasty	   is	   a	  common	  and	  costly	  procedure	  [36,	  37].	  Singh	  et.	  al	  [37]	  reported	  some	  factors	  that	  can	  be	  targeted	  for	  improvement	  of	  outcomes	  after	  THR	  such	  as	  gender,	  age	  and	  depression	  [37].	  Moreover,	  it	  was	  reported	  that	  the	  type	  of	  intervention	  and	  other	  patient-­‐related	  factors	  such	  as	  obesity	  were	  associated	  with	  poorer	  pain	  and	   function	  outcome	  after	   revision	  arthroplasty	  [37,	  38].	  Therefore,	  it	  is	  necessary	  a	  better	  understanding	  of	  the	  relation	  of	  comorbidities	  in	  the	  THA	  outcomes.	  	  
3.2.1.	  Causes	  of	  Revision	  Arthroplasty	  Revision	   arthroplasty	   is	   a	   common	  procedure	   that	   is	   performed	   increasingly	   often,	   as	  the	   population	   ages	   and	   improves	   the	   life	   quality	   of	   patients	   [39,	   40].	   Unfortunately,	  some	   surgical	   interventions	   are	   not	   successful	   and	   prosthetic	   hips	   fail,	   requiring	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revision	   [39].	   Usually	   the	   longevity	   of	   revision	   arthroplasty	   is	   inferior	   to	   primary	  arthroplasty	  [41].	  The	  most	   frequently	   reported	   causes	   of	   revision	   include	   aseptic	   loosening,	   osteolysis,	  infection,	  dislocation,	  instability	  and	  implant	  failure	  [40,	  42].	  Osteolysis,	  instability	  and	  aseptic	  loosening	  are	  considered	  the	  most	  common	  problems	  for	  both	  primary	  and	  revision	  arthroplasties	  [39,	  43].	  Also,	  aseptic	  loosening	  is	  a	  major	  clinical	   problem	   that	   causes	   pain	   in	   patients	   and	   lead	   to	   the	   need	   of	   a	   revision.	   The	  mechanisms	  underlying	  aseptic	  loosing	  are	  not	  totally	  defined	  but	  there	  are	  increasing	  evidences	  that	  the	  adverse	  tissue	  response	  to	  wear	  debris	  leads	  to	  osteolysis	  and	  bone	  resorption	  [44].	  	  Some	  patient-­‐related	  factors	  include	  comorbidities	  and	  affect	  the	  frequency	  of	  infections	  or	  dislocation	  in	  the	  patients	  [43].	  After	   aseptic	   loosening,	   dislocation	   is	   the	   most	   common	   complication	   of	   revision	  arthroplasty	   [45].	   Also,	   infection	   after	   primary	   arthoplasty	   is	   a	   common	   problem	   and	  microorganisms	  that	  colonize	  the	  implant	  surface	  can	  cause	  prosthesis	  loosening	  [46].	  A	   common	   complain	   of	   patients	   that	   undergo	   revision	   arthroplasty	   is	   pain	   in	   the	   hip,	  back	  or	   thigh.	  Determining	   the	   source	  of	   pain	   in	   these	  patients	   is	   frequently	   clinically	  challenging	  [40,	  47].	  Better	  strategies	  are	  needed	  to	  prevent	  and	  treat	  this	  often	  complications	  in	  primary	  hip	  arthoplasties	   in	   order	   to	   facilitate	   the	   initiation	   of	   appropriate	   treatment	   and	  prevent	  the	  need	  of	  revision.	  	  
3.2.2.	  Materials	  used	  in	  Hip	  Arthroplasties	  In	   primary	   arthroplasties,	   the	   spherical	   part	   of	   the	   joint	   is	   either	   completely	   replaced	  (conventional	   approach)	   or	   it	   is	   trimmed	   and	   covered	   by	   a	   metallic	   cap	   (resurfacing	  approach),	   and	   replace	   the	   damaged	   natural	   articulating	   surfaces.	   Consequently,	   the	  materials	  must	  have	  low	  friction	  and	  resist	  to	  wear	  and	  oscillating	  mechanical	  load.	  The	  femoral	  head	  is	  anchored	  in	  the	  femur	  by	  the	  stem.	  The	  acetabular	  cup	  is	  attached	  to	  the	  pelvis	  and	  is	  composed	  of	  a	  shell	  in	  which	  a	  liner	  is	  inserted	  to	  provide	  the	  load	  bearing	  articulating	   surface.	   These	   segmental	   designs	   allow	   using	   different	   materials	   with	  different	  properties	  and	  choose	  the	  most	  suitable	  for	  their	  function	  [48,	  49]	  	  Shell	   and	   stem	   have	   to	   provide	   good	   bone	   integration	   and	   are	   frequently	   made	   of	  titanium	  and	  titanium	  alloy,	  respectively.	  However,	  titanium	  alloys	  are	  not	  hard	  enough	  for	   low-­‐friction	   wear-­‐resistant	   articulating	   surfaces	   and	   other	   materials	   are	   used	   to	  meet	   the	   requirements	   for	   the	   articulating	   interface	   between	   head	   and	   cup.	   The	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frequently	   used	   notations	   metal-­‐on-­‐metal	   (MoM),	   ceramic-­‐on-­‐ceramic	   (CoC)	   or	   the	  classical	   combination	  metal-­‐on-­‐polyethylene	   (MoP)	   refer	   to	   the	   sequence	   of	  materials	  used	  for	  the	  femoral	  head	  and	  the	  acetabular	  cup	  (liner),	  respectively	  (Figure	  5.).	  	  The	   most	   critical	   complication	   with	   metal-­‐on-­‐polymer	   (MoP)	   prostheses	   is	   aseptic	  loosening	   due	   to	   an	   inflammatory	   reaction	   against	   polymer	   wear	   debris.	   Aseptic	  loosening	   is	  much	   less	   frequently	  encountered	   in	  patients	  with	  metal-­‐on-­‐metal	   (MoM)	  or	  ceramic-­‐on-­‐ceramic	  (CoC)	  prostheses.	  	  	  
    
Figure	  5.	  Examples	  of	  a	  (A)	  Metal	  and	  Highly	  Crosslinked	  Polyethylene	  implant;	  (B)	  Metal-­‐on-­‐Metal	  
implant;	   (C)	   Ceramic-­‐on-­‐Ceramic	   Implant.	   In	  
http://www.healthbase.com/resources/orthopedics/total-­‐hip-­‐replacement-­‐surgery	  implants/	  	  
Metallic	  prosthesis	  has	  high	  strength	  and	  toughness.	  The	  metals	  that	  are	  commonly	  used	  include	   titanium,	   stainless	   steel	   and	   cobalt	   chrome.	   However,	   it	   causes	   problems	   in	  human	  body	  due	  to	  corrosion,	  wear	  and	  adverse	  reaction	  with	  host	  tissues.	  The	  metallic	  ions	  produce	  soluble	  metallic	  salts	   that	  enter	   the	  body	   fluids	   like	  blood	  and	  urine	   [20,	  48].	  
	  
4.	  Inflammation	  Aseptic	   loosening	   of	   the	   implant	   after	   total	   joints	   arthroplasty	   is	   associated	   with	  remodeling	   of	   the	   bone	   and,	   along	   with	   osteolysis,	   remains	   the	   main	   long-­‐term	  problems	  of	  hip	  arthroplasty	  [50-­‐52].	  The	  inflammatory	  response	  to	  particulate	  wear	  debris	  manifests	  as	  a	  fibrous	  membrane	  between	   the	   implant	   and	   bone	   that	   is	   formed	   by	   macrophages,	   fibroblasts	   and	   giant	  cells.	   Macrophages	   are	   believed	   to	   be	   the	   responsible	   for	   many	   events	   associated	   to	  osteolysis	   and	   represent	   60-­‐80%	  of	   the	   cell	   population	   of	   the	   fibrous	  membrane	   that	  surrounds	  the	  prosthesis	  [50,	  51,	  53].	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It	   is	   believed	   that	   phagocytosis	   of	   particulate	   wear	   debris	   activate	   pro-­‐inflammatory	  cytokine	  signaling	  within	  this	   fibrous	  membrane	  macrophages	  and	  change	  the	  balance	  between	  osteoblasts	  and	  osteoclasts	  via	  induction	  of	  receptor	  activator	  of	  nuclear	  factor	  kappa-­‐B	  ligand	  RANKL	  -­‐	  the	  key	  osteoclastogenic	  cytokine	  in	  periprosthetic	  cells	  -­‐	  that	  is	  ultimately	   responsible	   for	   bone	   loss	   in	   osteolysis,	   as	   illustrated	   in	   Figure	   6.	   [52-­‐56].	  Cytokines	   usually	   have	   multiple	   overlapping	   activities,	   regulate	   each	   other,	   may	  interfere	   with	   receptor	   expression	   and	   activate	   the	   gene	   expression	   of	   certain	   bone-­‐resorbing	  agents	  such	  as	  metalloproteinases	  and	  cyclo-­‐oxygenases	  [57].	  However,	  it	  is	  still	  unknown	  the	  cellular	  mechanisms	  that	  are	  underlying	  this	  abnormal	  bone	   resorption	   and	   how	   the	   cells	   infiltrated	   in	   periprosthetic	   tissues	   contribute	   to	  osteolysis.	   Also,	   the	   nature	   of	   the	   cell	   types	   within	   the	   periprosthetic	   tissue	   remains	  unidentified	  [55,	  58].	  
 
Figure	  6.	   	  Simplified	  schematic	  of	  inflammatory	  response	  triggered	  by	  wear	  debris	  leading	  to	  bone	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In	   fact,	   Sabokbar	   et.	   al	   [55]	   demonstrated	   by	   immunohistochemistry	   studies	   that	   the	  inflammatory	  foreign	  body	  macrophage	  infiltrate	  in	  tissue	  surrounding	  loose	  prosthesis	  contain	   mononuclear	   osteoclast	   precursors	   that	   have	   phenotypic	   characteristics	   of	  macrophages.	  	  Since	   fibroblasts	  compose	  a	  great	  number	  of	   the	  cells	   in	   the	  periprosthetic	  membrane	  [59]	   it	   is	   also	   possible	   that	   they	   can	   be	   important	   targets	   in	   the	   cell	   and	   molecular	  cascades	  that	  regulate	  bone	  loss	  in	  primary	  arthoplasty	  [51].	  It	  was	  reported	  the	  importance	  of	  pro-­‐inflammatory	  cytokines	  in	  osteolysis,	  namely	  the	  observation	  that	  cytokines	  are	  produced	  when	  both	  cultured	  macrophage	   lineage	  cells	  and	  murine	  models	  of	  osteolysis	  are	  stimulated	  with	  wear	  particles	  and	  that	  when	  the	  pro-­‐inflammatory	   signaling	   cascade	   is	   blocked	   it	   can	   improve	   health	   in	   these	   animal	  models	   [50,	   52,	   54].	   Among	   the	   different	   cytokines,	   interleukin-­‐1β	   (IL-­‐1β)	  messenger	  ribonucleic	   acid	   (mRNA)	   was	   found	   to	   be	   present	   in	   macrophages	   retrieved	   from	  membranes	   surrounding	   loose	   prostheses.	   Also,	   tumour	   necrosis	   factor-­‐α	   (TNF-­‐α)	   is	  believed	  to	  be	  the	  principal	  cytokine	  in	  the	  osteolytic	  process	  since	  it	  is	  highly	  secreted	  after	  particles	  interact	  with	  cocultures	  of	  macrophages	  and	  osteoblasts	  [50,	  52].	  The	   role	   of	   cytokines	   in	   inflammatory	   reactions	   is	   well	   identified	   [60,	   61].	   The	   pro-­‐inflammatory	   cytokines	   IL-­‐1β,	   interleukin-­‐6	   (IL-­‐6)	   and	   TNF-­‐α	   are	   described	   by	   being	  up-­‐regulated	   in	   macrophages	   and	   fibroblasts	   in	   response	   to	   wear	   debris	   [56,	   60].	  Among	  the	  pro-­‐inflammatory	  cytokines,	  IL-­‐6	  is	  believed	  to	  have	  a	  central	  role	  in	  injury	  [60]	  since	  systemic	  complications	  are	  associated	  with	  a	  sustain	  elevation	  of	  IL-­‐6	  levels	  [61-­‐63].	  Along	  with	  immune	  system,	  the	  nervous	  system	  has	  been	  implicated	  in	  the	  pathogenesis	  of	   joint	   diseases	   since	   pain,	   osteolysis	   and	   joint	   effusion	   are	   problems	   that	   persist	   in	  some	  cases	  after	  a	  hip	  replacement.	  When	  the	  problem	  of	  infection	  has	  been	  excluded,	  it	  should	   be	   suspected	   an	   immunological	   response.	   The	   factors	   that	   contribute	   to	  postoperative	   pain	   include	   prostaglandin	   E2	   and	   cytokines	   that	   are	   found	   to	   be	   up-­‐regulated	  in	  wound	  exudates	  [64,	  65].	  	  
5.	  Pain	  in	  Hip	  joint	  -­‐	  Where	  does	  pain	  come	  from?	  Determining	   the	  etiology	  of	  pain	  after	  primary	  arthoplasty	   can	  be	  a	  difficult	   challenge	  [66].	   Although	   there	   have	   been	   remarkable	   developments	   in	   surgical	   factors	   such	   as	  technique	   and	   implant	   design,	   some	   patients	   still	   experience	   pain	   after	   primary	  arthroplasty	  [67].	  Stress	  fractures,	  vascular	  lesions	  and	  inflammation	  of	  soft	  tissues	  such	  as	  bursitis	  or	  tendonitis	  are	  found	  to	  cause	  pain	  in	  these	  patients	  [66].	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Pain	  related	  to	  the	  hip	  is	  frequent	  in	  patients	  with	  rheumatoid	  arthritis	  (RA)	  [68].	  RA	  is	  a	  chronic	  and	  progressive	  disease	  that	  affects	  the	  peripheral	  joints.	  	  It	  can	  cause	  severe	  disability	  and	  loss	  of	  function	  coupled	  with	  pain	  in	  about	  15%	  of	  people	  that	  express	  a	  particularly	  severe	  form	  of	  the	  RA	  [69].	  Another	  occurring	  problem	  is	  trochanteric	  pain,	  also	  known	  as	  trochanteric	  bursitis	  that	  is	   expressed	   in	  10-­‐20%	  of	   all	  patients	  with	   lower	  back	  pain	  or	  OA	  of	   the	  hip	  and	   it	   is	  believed	  to	  be	  one	  of	  the	  first	  symptoms	  developed	  in	  OA	  [70].	  In	  order	  to	  determine	  the	  source	  of	  hip	  pain	  it	  should	  be	  done	  local	  specific	  examination	  since	  painful	  hip	  is	  a	  very	  challenging	  problem	  in	  orthopedic	  surgery	  and	  it	  can	  have	  a	  wide	  range	  of	  diagnoses	  [71]	  	  Hip	  pain	  is	  a	  result	  of	  a	  stimulation	  of	  free	  endings	  in	  nerve	  fibers	  by	  nociceptive	  agents	  and	  by	  chemical	  agents	  namely	  bradykinin	  or	  histamine.	  Also,	  some	  molecules	  such	  as	  substance	   P	   (SP)	   and	   prostaglandins	   can	   increase	   the	   sensitivity	   to	   pain	   [72].	   It	   was	  reported	  that	  SP	  induces	  release	  of	  cytokines	  such	  as	  IL-­‐1β	  and	  TNF-­‐α	  in	  human	  dental	  pulp	   fibroblasts	   [73]	   and	   it	   can	   be	   considered	   as	   a	   pro-­‐inflammatory	   and	   painful	  stimulus	  [51,	  74].	  	  
5.1.	  Neurovascular	  injury	  
The	  number	  of	  primary	  and	  revision	  arthroplasties	  has	  been	  increasing	  over	  the	  years	  [75].	  Although	  joint	  arthroplasties	  surgeries	  are	  among	  the	  most	  successful	  procedures	  [76]	  that	  relief	  pain	  and	  increase	  quality	  of	  life	  for	  patients	  [77],	  the	  number	  of	  primary	  arthroplasties	   is	   increasing	   and,	   therefore,	   special	   care	   should	   be	   taken	   in	   revision	  arthroplasties	  [75].	  Despite	  Total	  joint	  arthroplasty	  (TJA)	  is	  considered	  a	  safe	  surgery	  [77],	  the	  development	  of	   neurovascular	   complications	   can	   occur	   [77-­‐80].	   Peripheral	   neuropathies	   are	   an	  uncommon	  but	  potentially	  devastating	  complication	  that	  are	  associated	  with	  significant	  morbidity	  and	  mortality	  [78,	  80,	  81].	  Hip	   is	  proximate	   to	  neurological	  and	  vascular	  structures	   leading	   to	  direct	  and	   indirect	  injury	  during	  surgical	  procedure	  [79].	  Common	  mechanisms	  of	  injury	  include	  laceration,	  malpositioned	   of	   the	   internal	   fixation	   devices,	   mechanical	   deformation	   derived	   from	  compression,	  traction,	  ischemia	  and/or	  direct	  transection	  [78,	  82].	  Using	  animal	  models	  it	  was	  possible	  to	  verify	  that	  peripheral	  nerves	  are	  especially	  sensitive	  to	  compression	  [82].	  Also,	  joint	  arthroplasty	  itself	  exert	  mechanical	  forces	  that	  may	  lead	  to	  compression	  or	   stretching	   of	   vascular	   structures;	   similarly	   stretching,	   retraction	   or	   direct	  impingement	  on	  the	  nerves	  after	  local	  pressure	  from	  cement	  can	  cause	  nerve	  palsy	  [77,	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78].	  Vascular	  injury	  after	  TJA	  poses	  a	  serious	  threat	  to	  patients’	  life	  and	  has	  an	  incidence	  of	  about	  0.2%,	  although	  in	  patients	  with	  prior	  vascular	  problems	  such	  as	  atherosclerosis,	  coronary	   bypass	   surgery	   and	   decreased	   distal	   pulses	   the	   risk	   of	   vascular	   problems	   is	  considerably	  higher	  [77,	  81].	  The	  incidence	  of	  clinical	  nerve	  injuries	  varies	  from	  1%	  to	  2%,	  but	  female	  patients,	  revision	  cases	  and	  cases	  of	  developmental	  dysplasia	  of	  the	  hip	  have	  a	  higher	  risk	  of	  nerve	  injuries	  [79].	  Several	  studies	  using	  hip	  arthroplasties	  reported	  the	  sciatic	  nerve	  as	  the	  most	  common	  injured	  nerve,	   since	   it	   is	   intimately	   related	   to	   the	  posterior	  portion	  of	   the	  acetabulum	  and	  femur	  [79,	  80,	  83].	  Femoral	  nerve	  injuries	  are	  the	  second	  most	  common	  injuries	  but	  rarely	   involve	   sustained	   disability	   as	   some	   muscles	   usually	   protect	   it	   [79,	   80,	   83].	  Intrapelvic	   extrusion	  of	   cement	   can	   cause	   injury	  of	   the	  obturator	  nerve,	   although	   it	   is	  not	  frequent.	  Injury	  of	  the	  superior	  gluteal	  nerve	  may	  be	  attributed	  to	  a	  variety	  of	  causes	  and	  the	  prevalence	  is	  not	  clear	  though	  it	  is	  thought	  to	  be	  rare	  [79].	  Neurovascular	   complications	   associated	   with	   TJA	   cannot	   be	   eliminated	   but	   can	   be	  reduced	  by	  cautious	  consideration	  of	  the	  structures	  at	  risk,	  careful	  operative	  technique	  and	   a	   detailed	   knowledge	   of	   local	   anatomy	   in	   order	   to	   minimize	   the	   chance	   of	  permanent	  complications	  [78,	  79,	  83].	  Since	  a	  higher	  number	  of	  revision	  surgeries	  are	  being	  carried	  on	  each	  year	  it	  is	  possible	  that	  the	  number	  of	  neurovascular	  injury	  complications	  can	  increase	  [77].	  It	  is,	  therefore,	  necessary	   further	   clinical	   and	   experimental	   studies	   to	   explore	   methods	   in	   order	   to	  reduce	   the	   risk	   for	   neurovascular	   injuries	   and	   increase	   quality	   of	   life	   for	   patients	  undergoing	  TJA	  [75].	  	  
5.2.	  Therapy	  -­‐	  Current	  available	  therapies	  and	  perspectives	  
There	   is	   much	   debate	   between	   clinicians	   about	   the	   best	   approach	   to	   the	  management	  of	  joint	  pain	  [84].	  Since	  OA	  is	  the	  most	  common	  disease	  affecting	  joints	  and	  causes	   pain	   and	   limited	   function,	   drugs	   are	   usually	   administrated	   to	   the	   patients	   in	  order	   to	   avoid	   revision	   surgery	   [85].	   Drug	   therapy	   should	   be	   individualized	   after	  assessing	   some	   features	   about	   the	   patient	   such	   as	   symptom	   severity,	   comorbid	  condition,	  side	  effects	  and	  patient	  conditions	  [85].	  Systemic	   drugs	   that	   are	  widely	   used	   in	   general	   practice	   consist	   in	   non-­‐steroidal	   anti-­‐inflammatory	   drugs	   (NSAIDs),	   paracetamol,	   glucosamine	   and	   chondroitin	   and	   opioids	  [84,	  85].	  Also,	  glucocorticoids	  and	  visco	  supplementation	  with	  hyaluran	  can	  be	  injected	  to	  relieve	  pain	  [85].	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Paracetamol	  should	  be	  used	  as	  initial	  therapy	  because	  NSAIDs	  are	  associated	  with	  risks	  of	   cardiovascular	   and	   cerebrovascular	   toxicity	   [85,	   86].	   Also,	   NSAIDs	   are	   reported	   to	  inhibit	  new	  bone	  formation,	   interfering	  with	  prosthetic	   fixation,	   inducing	  a	  destructive	  arthroplasty	   involving	  both	  femoral	  and	  acetabular	  components	  of	   the	  hip	  and	   leading	  to	   THR	   [86-­‐88].	   An	   alternative	   to	   NSAIDs	   is	   acetaminophen	   that	   was	   shown	   to	   have	  similar	  efficacy	  compared	  to	  NSAIDs	  and	  safer	  for	  patients	  [89].	  Another	  alternative	  to	  avoid	  systemic	  complications	   is	   to	  control	  pain	  using	  a	  regional	  block	   on	   femoral	   or	   in	   fascia-­‐iliaca	   nerves.	   Since	   inadequate	   pain	   relief	   contributes	   to	  delayed	   recovery	   from	   hip	   fractures	   it	   should	   be	   performed	   a	   careful	   study	   of	   the	  patient	  in	  order	  to	  prescribe	  the	  best	  drug	  therapy	  [85,	  90].	  
	  
	  
B.	  The	  Neuro-­‐immuno-­‐osteogenic	  network	  	  Bone	   homeostasis	   and	   remodeling	   occur	   during	   growth	   in	   all	   bony	   animals	   [91].	   To	  achieve	   this,	   in	   cases	   of	   disease	   or	   increasing	   mechanical	   demands,	   bone	   cells	   can	  enhance	   bone	   formation	   or	   bone	   degradation.	   Initially,	   it	  was	   believed	   that	   this	   bone	  adaptive	   response	   was	   only	   controlled	   by	   growth	   factors,	   cytokines	   and	   systemic	  hormones;	   however,	  many	   studies	   reported	   that	   bone	   could	   also	   be	   regulated	   by	   the	  nervous	   system	   leading	   to	   the	   believe	   that	   central	   nervous	   system	   (CNS)	   plays	   an	  important	   role	   in	   bone	   remodeling	   [91,	   92].	  Moreover,	   it	   has	   been	  demonstrated	   that	  bone	   cells	   have	   functional	   receptors	   for	   many	   neuro-­‐osteogenic	   factors	   and	   that	  signaling	  molecules	  derived	  from	  nervous	  system	  can	  participate	  in	  the	  control	  of	  bone	  metabolism,	  leading	  to	  the	  conclusion	  that	  there	  must	  be	  a	  strong	  relationship	  between	  bone	  and	  brain	  and	  supporting	  the	  existence	  of	  a	  neuro-­‐osteogenic	  regulatory	  pathway	  [93-­‐97].	  Also,	   immunohistochemistry	   studies	   revealed	   that	   bone,	   bone	   marrow	   and	   the	  periosteum	  have	  a	  rich	  supply	  of	  neuropeptide	  fibers	  [97].	  	  Bone	  cells	  and	  immune	  cells	  interact	  and	  regulate	  each	  other	  since	  bone	  marrow	  spaces	  are	   poorly	   compartmentalized	   (Figure	   2.).	   Therefore,	   when	   the	   immune	   system	   is	  activated	   or	   becomes	   diseased,	   these	   two	   systems	   influence	   each	   other	   leading	   to	  alterations	  of	  bone	  homeostasis	  [98].	  	  It	   has	   been	   studied	   the	   relationship	   between	   muscle-­‐skeletal	   system	   and	   nervous	  system	   for	   many	   years	   [99].	   It	   is	   known	   that	   some	   inflammatory	   diseases	   such	   as	  multiple	   sclerosis	   and	   rheumatoid	   arthritis	   are	   associated	   with	   changes	   in	   the	  sympathetic	  nervous	  system	  [100].	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Both	   sensory	  and	  sympathetic	  nerve	   fibers	  are	  present	   in	  bone,	   including	  periosteum,	  bone	  marrow	  and	  mineralized	  bone	   [92].	  Bone	   cells	   express	  a	  variety	  of	  nerve	   fibers-­‐containing	   neuro-­‐active	   peptides	   such	   as	   vasoactive	   intestinal	   polypeptide	   (VIP),	  calcitonin	   gene-­‐related	   peptide	   (CGRP)	   [101],	   pituitary	   adenylate	   cyclase	   activating	  peptides	   (PACAP),	   neuropeptide	   Y	   (NPY)	   [102],	   SP	   [101],	   as	   well	   as	   some	   classical	  neuromediators	  such	  as	  noradrenaline,	  glutamate	  and	  serotonin	  [103-­‐105].	  Also,	  it	  was	  found	  in	  pseudocapsular	  tissues	  some	  SP-­‐	  and	  CGRP-­‐immunoreactive	  nerve	  fibers	  [106].	  Nerve	   fibers	   are	   frequently	   associated	   to	   blood	   vessels	   and	   it	   is	   known	   that	  neuromediators	   derived	   from	   sympathetic	   nervous	   system	   control	   blood	   flow	   [103,	  107].	   Another	   possibility	   is	   that	   this	   neuromediators	   released	   by	   nerve	   fibers	   can	   act	  indirectly	  in	  the	  regulation	  of	  cytokines	  expression	  by	  cells	  of	  the	  immune	  system	  and,	  therefore,	  control	  bone	  cell	  functions	  [103,	  107,	  108].  
 
Figure	  7.	  A	  schematic	  diagram	  of	  bone	  environment.	  From	  [98].	  	  This	   extensive	   tissue-­‐nervous	   system	   communication	   associated	   with	   neuropeptides	  [107]	   can	   be	   observed	   in	   the	   interface	   membrane	   surrounding	   loose	   prostheses	   that	  shows	   a	   chronic	   inflammation,	   characterized	   by	   a	   granulomatous	  membrane	   between	  the	  implant	  and	  bone	  that	  is	  infiltrated	  with	  macrophages,	  lymphocytes,	  fibroblasts	  and	  foreign-­‐body	  giant	  cells	  [51,	  108,	  109].	  Additionally,	   Ahmed	   et.	   al	   [109]	   reported	   the	   presence	   of	   nerve	   fibers	   containing	  autonomic	  neuropeptides	  such	  as	  NPY	  and	  VIP	  by	  immunohistochemistry	  studies	  in	  the	  interface	   membrane	   of	   aseptic	   loose	   cemented	   hip	   prostheses	   [109],	   which	   may	   be	  assumed	  to	  mediate	  pain	  and	  inflammatory	  responses	  [106].	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Altogether,	  these	  evidences	  suggest	  that	  the	  presence	  of	  nerve	  fibers	  in	  bone	  tissue	  and	  the	  constant	  changes	  in	  its	  distribution	  during	  bone	  regeneration	  and	  development	  can	  have	  a	  role	  in	  the	  local	  regulation	  of	  bone	  metabolism	  [97].	  Among	   the	   several	   neuropeptides	   present	   in	   bone,	   the	   NPY	   system	   emerges	   as	   a	  potential	   candidate	   illustrating	   the	  complex	   interactions	  between	  neural	   signaling	  and	  bone	  homeostasis	  [110-­‐114].	  However,	  the	  molecular	  and	  cellular	  details	  are	  still	  being	  unraveled,	  transforming	  this	  concept	  into	  an	  important	  area	  of	  research	  in	  bone	  biology.	  
	  
	  
1.	  Neuropeptide	  Y	  (NPY)	  NPY	   is	   a	   36-­‐amino	   acid	  peptide,	   originally	   isolated	   and	   sequenced	   from	  porcine	  brain	  and	   derives	   its	   name	   from	   its	  N-­‐	   and	   C-­‐terminal	   tyrosines	   (Y)	   [97,	   115].	   It	   has	   been	  found	   in	   all	   mammals	   making	   NPY	   one	   of	   the	   most	   evolutionary	   conserved	   peptides	  known	  among	  mammalian	  species	  [97,	  115,	  116].	  NPY	   is	  widely	   expressed	   in	   the	   central	   and	   peripheral	   nervous	   system	   (PNS)	   and	   has	  been	   shown	   to	   play	   an	   important	   role	   in	   numerous	   physiological	   processes	   such	   as	  feeding	   behavior,	   cortical	   neural	   activity,	   energy	   balance,	   vasoconstriction,	   bone	  formation,	   heart	   activity	   and	   anxiety	   as	   well	   as	   in	   several	   human	   diseases	   including	  obesity,	  alcoholism	  and	  depression	  [97,	  100,	  117,	  118].	  
	  
1.1.	  NPY	  receptors	  	  
The	  NPY-­‐family	  is	  constituted	  by	  NPY	  and	  the	  intestinal	  PYY	  and	  PP,	  two	  other	  36-­‐amino	  acid	   endocrine	   hormones.	   All	   of	   them	   mediate	   their	   effects	   through	   activation	   of	   G	  protein-­‐coupled	   receptors	   termed	   Y	   receptors	   [97,	   116].	   Five	   Y	   receptors	   have	   so	   far	  been	   identified	   in	   mammals:	   Y1,	   Y2,	   Y4,	   Y5	   and	   y6	   in	   mice,	   each	   showing	   varying	  distributions	  across	  central	  and	  peripheral	  tissues	  [100,	  116,	  118-­‐120].	  
Figure	  8.	  Schematic	  structure	  of	  the	  amino	  acid	  sequence	  of	  human	  NPY	  [97]	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  NPY	  and	  its	  receptors	  are	  ubiquitously	  expressed	  throughout	  the	  body.	  In	  the	  CNS,	  they	  are	   located	  in	  regions	  such	  as	  hypothalamus,	  cerebral	  cortex,	  brain	  stem,	  striatum	  and	  limbic	  structures.	  NPY	   is	  also	   found	   in	   the	  sympathetic	  nervous	  system,	  co-­‐stored	  and	  co-­‐released	  with	  noradrenaline	  during	  nerve	  stimulation	  [117,	  118].	  Many	  non-­‐CNS	  cell	  types	   also	   express	   NPY	   receptors,	   namely	   Y1	   is	   detected	   on	   immune	   cells	   including	  macrophages,	   T	   cells,	   B	   cells,	   dendritic	   cells,	   mast	   cells	   and	   natural	   killer	   cells	   [100].	  Also,	   NPY	   and	   Y1	   and	   Y2	   receptors	   were	   identified	   as	   key	   regulators	   of	   bone	  homeostasis	  in	  a	  neural	  and	  neuroendocrine	  way	  [120].	  NPY	  and	  Y1	  receptor	  are	  highly	  expressed	  at	   sites	  of	  pain	   transmission,	  placing	   the	  NPY	  system	  as	  a	  key	  player	   in	   the	  development	  of	  pathological	  pain	  [121].	  Despite	   generally	   low	   sequence	   similarity	   within	   the	   Y	   receptor	   family,	   they	   all	   use	  similar	   signal	   transduction	   pathways	   and	   mediate	   their	   response	   though	   Gi	   or	   G0	  proteins	   (Figure	  1.2),	   inhibiting	   the	  accumulation	  of	   cyclic	  adenosine	  monophosphate	  (cAMP)	  by	  decreasing	  its	  production	  in	  the	  cell	  [116,	  117].	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	    
Figure	  9.	  Typical	  intracellular	  signaling	  cascades	  for	  NPY	  receptors.	  All	  NPY	  receptors	  are	  coupled	  to	  
the	   Gi	   signaling	   cascades.	   Initiation	   of	   these	   cellular	   signaling	   cascades	   leads	   to	   the	   initiation	   of	  
transcription	   and,	   therefore,	   the	   stimulation	   or	   inhibition	   of	   hormone/neurotransmitter	   release	  
[117].	  
	  
1.2.	  Substance	  P	  (SP)	  
SP	  is	  an	  11	  amino	  acid	  neuropeptide	  that	  belongs	  to	  a	  family	  of	  bioactive	  peptides,	  the	  tachykinins,	   also	   known	   as	   the	   neurokinins.	   The	   tachykinins	   are	   defined	   by	   their	  common	   pharmacological	   properties	   and	   conserved	   carboxyl-­‐terminal	   sequences.	  Moreover,	  the	  principal	  biological	  activities	  of	  SP	  consist	  in	  its	  carboxyl	  sequence	  [115,	  122,	  123].	   	  There	  are	  other	   tachykinins	  such	  as	  neurokinin	  A	   (NKA)	  and	  neurokinin	  B	  (NKB).	  SP	  and	  NKA	  are	  derived	  from	  the	  same	  gene,	   the	  preprotachykinin	  A	  gene,	  and	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are	   retrieved	   as	   a	   result	   of	   alternative	   splicing	   of	   a	   common	   transcription	   product.	  Although	   the	   underlying	   mechanisms	   remain	   unclear,	   this	   common	   gene	   has	   been	  shown	   to	   be	   induced	   by	   cytokines,	   glucocorticoids,	   neuropeptides	   and	  lipopolysaccharides	  (LPS)	  [115].	  	  The	   biologic	   effects	   of	   SP	   are	   mediated	   through	   interactions	   with	   G	   protein-­‐coupled	  receptors.	   Three	   types	   of	   receptors	   have	   been	   cloned:	   neurokinin-­‐1R	   (NK1	  R),	  NK-­‐2R	  and	   NK-­‐3R;	   although	   subtypes	   of	   each	   the	   NK-­‐R	   have	   been	   suggested	   it	   is	   usually	  accepted	  that	  SP	  shows	  a	  higher	  affinity	  for	  NK-­‐1	  and	  a	  lesser	  affinities	  for	  NK-­‐2	  and	  NK-­‐3	  [124].	  SP	  has	  a	  wide	  distribution	  in	  the	  CNS	  and	  PNS,	  gastrointestinal	  tracts,	  and	  in	  endocrine	  tissues,	  and	  is	  richly	  distributed	  in	  the	  sensory	  nerve	  fibers	  [122,	  125,	  126].	  It	  is	  mainly	  synthesized	   at	   dorsal	   root	   ganglions	   following	   nerve	   growth	   factor	   stimulation	   and	  afterwards	  is	  transported	  to	  the	  peripheral	  primary	  afferent	  end	  organs,	  being	  released	  peripherally	  after	  afferent	  activation	  [122,	  127].	  SP	  present	  in	  tissues	  can	  be	  originated	  from	  neural	  and/or	  non-­‐neural	  sources;	  neural	  sources	  of	  SP	  comprise	  the	  cell	  body	  of	  neurons	   and	   nerve	   terminals	   while	   non-­‐neural	   sources	   include	   macrophages	   and	  eosinophils	  [124].	  It	  was	  shown	  that	  in	  peripheral	  tissue	  SP	  stimulates	  vascular	  dilatation,	  increases	  blood	  vessel	   permeability,	   modulates	   blood	   flow,	   and	   induces	   angiogenesis	   in	   the	   bone	  marrow	  [122].	  Also,	   it	  was	  described	  that	  SP	   increases	  osteoblast	  differentiation,	  bone	  colony	  formation	  and	  osteoblastic	  cAMP	  production,	  which	  controls	  osteoblast	  functions	  and	   activation	   [126,	   128].	   In	   fact,	   SP	   was	   identified	   in	   the	   most	   active	   areas	   of	  osteogenesis	  such	  as	  growth	  plate,	  periosteum,	  and	  bone	  marrow	  leading	  to	  believe	  that	  SP	  can	  be	  one	  of	  the	  modulating	  factors	  in	  bone	  metabolism	  [129,	  130].	  	  The	   inflammation	   caused	   by	   the	   release	   of	   neuropeptides	   such	   as	   SP	   is	   known	   as	  neurogenic	  inflammation	  [122].	   	  SP	  is	  a	  powerful	  inflammatory	  agent	  in	  the	  joint	  fluid,	  permitting	   the	   extravasation	   of	   plasma	   proteins	   into	   the	   synovial	   cavity,	   making	   it	   a	  commonly	  used	  marker	  of	  inflammation	  in	  the	  joint	  [127,	  131].	  In	  patients	  with	  chronic	  arthritis,	   the	   concentration	  of	   SP	   in	   joint	   fluid	   and	   serum	   is	   increased	   leading	   to	   joint	  pain	  and	  accelerating	  synovitis	  [122,	  129].	  
THR	   is	   one	  of	   the	  most	   common	  and	   successful	   orthopedic	  procedures	   and	   it	   offers	   a	  valuable	   option	   in	   the	  management	   of	   pain	   and	  disability	   of	   patients.	   There	   are	   some	  aspects	  that	  should	  be	  clarify	  such	  as	  the	  cascade	  of	  events	  and	  cellular	  responses	  that	  happens	   in	   osteolysis.	   There	   is	   a	   need	   of	   a	   better	   management	   of	   patients	   pain	   and	  further	  studies	  to	  predict	  infection,	  loosening,	  fracture	  and	  instability	  after	  THR.	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C.	  Aim	  of	  Studies	  
	  
This	   work	   aims	   to	   characterize	   NPY,	   SP	   and	   Pro-­‐inflammatory	   cytokines	  expression	   profile	   and	   distribution	   in	   the	   interface	   membrane	   that	   surrounds	  loose	  prosthesis	  of	  patients	  submitted	  to	  hip	  arthroplasties,	  in	  order	  to	  evaluate	  the	  impact	  of	  the	  neuropeptides	  in	  the	  modulation	  of	  the	  inflammatory	  response.	  	  	  For	  this	  goal	  we	  will:	  
 Evaluate	   the	   neuropeptides	   and	   pro-­‐inflammatory	   cytokines	   expression	  profile	   in	   patients’	   tissues	   retrieved	   from	   capsule	   in	   Primary	   and	   Revision	  arthroplasties.	  
 Study	  the	  NPY	  system	  in	  the	  macrophages	  inflammatory	  response	  to	  wear	  debris	  with	  NPY	  system	  activity.	  	  
	  
Figure	  10.	  Schematic	  representation	  of	  the	  aim	  of	  studies.	  In	  bone	  compartment	  there	  is	  a	  complex	  
interaction	   between	   immune	   cells,	   bone	   cells	   and	   nerve	   fibers.	   Thus,	   it	   is	   possible	   that	   bone	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The	   following	   tables	   include	   the	   reagents	   used	   for	   each	   step	   of	   the	   experimental	  procedure	  as	  well	  as	  the	  references	  and	  suppliers.	  
	  
Table	  1.	  Cell	  culture	  reagents	  
Reagent	   Reference/Supplier	  RPMI	  1640	  +	  L-­‐Glutamine	   11875-­‐093	  (Invitrogen)	  Penicillin/Streptomycin	  (P/S)	   15140-­‐122	  Gibco	  (Invitrogen)	  Fetal	  Bovine	  Serum	  (FBS)	   DE14-­‐801FH	  (Lonza)	  Phorbol	  12-­‐miristate	  13-­‐acetate	  (PMA)	   P8139-­‐1MG	  (Sigma-­‐Aldrich)	  Phosphate	  Buffer	  saline	  (PBS):	  Sodium	  Chloride	  (NaCl)	  Potassium	  Chloride	  (KCl)	  Sodium	  Phosphate,	  Dibasic	  (Na2HPO4)	  Potassium	  Phosphate	  Monobasic	  (KH2PO4)	  
	  106404	  (Merck	  Chemicals)	  P8041	  (Sigma-­‐Aldrich)	  106586	  (Merck	  Chemicals)	  P5655	  (Sigma-­‐Aldrich)	  Resazurin	   R7017-­‐5G	  (Sigma-­‐Aldrich)	  	  
Table	  2.	  Total	  RNA	  extraction	  
Reagent	   Reference	  RNAlater	   76104	  (QIAGEN)	  TRIzol®	  Reagent	  	   15596-­‐018	  (Invitrogen)	  PureLinkTM	  RNA	  Mini	  Kit	   12183-­‐018A	  (Invitrogen)	  
	  
Table	  3.	  mRNA	  expression	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Table	  4.	  Immunocytochemistry	  
Reagent	   Reference	  Albumin,	  Bovine	  Serum,	  Fraction	  V	  (BSA)	   122605	  (Merk	  Chemicals)	  Triton	  X-­‐100	   X-­‐100	  (Sigma)	  Proteinase	  K	   Sigma	  Sodium	  Borohydride	   452173-­‐100G	  (Sigma-­‐Aldrich)	  
Anti-­‐NPY	  Antibody	  produced	  in	  mouse	   Kindly	  offer	  by	  E.	  Grouzmann,	  University	  Hospital,	  Lausanne,	  Switzerland	  Anti-­‐NF200	  rabbit	  polyclonal	  antibody	  	   ab8135	  (Abcam)	  Alexa	  Fluor	  568	  Donkey	  anti-­‐mouse	   A10037	  (Invitrogen)	  Alexa	  Fluor	  568	  donkey	  anti-­‐rabbit	  IgG	   A10042	  (Invitrogen)	  Vectashield	  Mounting	  Medium	  with	  DAPI	   H1200	  (Vector	  Laboratories)	  	  
Table	  5.	  Immunohistochemistry	  	  
Reagent	   Reference	  Hydrogen	  Peroxide	  3%	   Prolabo	  Protein	  Blocking	   X0909	  (Dako)	  Anti-­‐CD68	  Antibody	  produced	  in	  mouse	   Leica	  (Menarini	  Diagnósticos)	  Streptavidin-­‐Biotin	  HRP	  solution	   Vectastain	  Elite	  ABC	  Reagent	  DPX	  Mountant	  for	  histology	   44581	  (Sigma-­‐Aldrich)	  DAB	  (3,3-­‐diaminobendidine)	   D	  3939	  (Sigma-­‐Aldrich)	  	  
Table	  6.	  Flow	  Cytometry	  Reagents	  
Reagent	   Reference	  Anti-­‐CD14	  Antibody*PE	   301805	  (Biolegend)	  Sodium	  Azide	   S2002	  (Sigma)	  EDTA	   ED	  2SS	  (Sigma)	  	  
Table	  7.	  Live-­‐Dead	  Assay	  
Reagent	   Reference	  Calcein	   C3100MP	  (Invitrogen)	  EtDh-­‐1	   E1169	  (Invitrogen)	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A.	   Neuropeptides	   and	   Pro-­‐inflammatory	   Cytokines	  
expression	  in	  patients	  undergoing	  Primary	  and	  Revision	  
Hip	  Arthroplasties	  	  	  
1.	  Patients	  This	  study	  comprises	  15	  hip	  revision	  cases	  and	  15	  primary	  cases	  retrieved	  from	  capsule.	  Some	   features	   about	   the	   patients	   that	   are	   included	   in	   this	   study,	   namely	   their	  designation	  along	  the	  report,	  age,	  gender	  and	  cause	  of	  surgery	  are	  presented	  in	  Table	  8.	  	  	  
Table	  8.	  Information	  about	  patients	  undergoing	  THA	  and	  THR.	  	  
Primary	  
Arthoplasties	  
Age	   Gender	   Cause	  of	  	  
Surgery	  
Revision	  
Arthroplasties	   Age	   Gender	   Cause	  of	  Surgery	  
INEB	  01	   79	   F	   Femur	  Fracture/Arthritis	   INEB	  031	   56	   M	   Implant	  failure	  
INEB	  02	   45	   F	   Osteoarthritis	   INEB	  033	   75	   M	   -­‐	  
INEB	  03	   54	   F	   Osteoarthritis	   INEB	  035	   80	   F	   Osteolysis	  
INEB	  04	   80	   F	   Osteoarthritis	   INEB	  036	   85	   F	   Pain/Osteolysis	  
INEB	  05	   55	   M	   Osteoarthritis	   INEB	  037	   60	   F	   Pain/Osteolysis	  
INEB	  06	   49	   F	   Pseudo-­‐arthrosis	   INEB	  038	   70	   M	   Pain/Osteolysis	  
INEB	  07	   76	   M	   Osteoarthritis	   INEB	  039	   65	   F	   Pain/Osteolysis	  
INEB	  08	   51	   F	   -­‐	   INEB	  040	   65	   F	   Pain/Osteolysis	  
INEB	  09	   -­‐	   F	   Osteoarthritis	   INEB	  042	   61	   F	   Pain/Osteolysis	  
INEB	  010	   -­‐	   M	   Osteoarthritis	   INEB	  043	   -­‐	   M	   Aseptic	  Loosening	  
INEB	  011	   74	   F	   Osteoarthritis	   INEB	  044	   70	   F	   Pain/Osteolysis	  
INEB	  012	   83	   M	   Osteoarthritis	   INEB	  045	   -­‐	   F	   Bad	  component	  orientation	  
INEB	  013	   37	   F	   Osteoarthritis	   INEB	  046	   -­‐	   F	   Fracture	  
INEB	  014	   74	   M	   Osteoarthritis	   INEB	  047	   60	   F	   Pain/Osteolysis	  
INEB	  015	   -­‐	   M	   Femur	  Fracture	   INEB	  048	   -­‐	   F	   Acetabular	  detachment	  F-­‐	  Feminine/	  M-­‐	  Masculine/	  -­‐	  Data	  not	  available	  	  
1.1.	  Samples	  Collection	  
A	   trained	  orthopedic	   surgeon	   explained	   to	   the	  patients	   the	   objective	   of	   the	   study	   and	  asked	  if	  he/she	  agrees	  in	  taking	  part	  of	  it,	  before	  signing	  a	  letter	  of	  consent.	  Afterwards,	  a	   questionnaire	   was	   filled	   gathering	   relevant	   information	   including	   the	   implant	  materials	  used	  and	  observations	  during	  the	  surgery.	  This	  questionnaire	  has	  received	  the	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approval	   of	   Centro	   Hospitalar	   de	   São	   João	   and	   Centro	   Hospitalar	   Vila	   Nova	   de	   Gaia/	  Espinho	  Ethic	  Committees.	  General	  information	  about	  patients	  is	  present	  in	  Table	  8.	  During	   surgery,	   discarded	   bone	   and	   soft	   tissues	   from	   capsular	   region	  were	   collected.	  Immediately	  after	  resection,	   the	   tissues	  were	  divided	   into	  aliquots.	  From	  each	  sample,	  part	   of	   the	   tissues	   was	   immediately	   submerged	   in	   RNAlater	   Stabilization	   Reagent	  (QIAGEN)	   to	   maintain	   the	   RNA	   integrity	   and	   was	   transported	   to	   the	   Instituto	   de	  Engenharia	   Biomédica	   in	   dry	   ice.	   The	   other	   tissue	   sample	   was	   fixed	   with	   3,7%	  formaldehyde	  solution	  for	  further	  histological/immunohistochemical	  analysis.	  	  	  
1.2.	  mRNA	  expression	  levels	  
1.2.1.	  Optimization	  of	  tissue	  homogenization	  Capsule	   samples	   that	   were	   used	   to	   extract	   total	   RNA	  were	   kept	   in	   RNAlater	   solution	  overnight	   at	   4˚C	   to	   allow	   thorough	   penetration	   of	   the	   tissue.	   In	   the	   following	   day	   the	  tubes	  were	  stored	  at	  	  -­‐80˚C	  until	  total	  RNA	  extraction.	  	  Total	  RNA	  extraction	  from	  capsule	  samples	  was	  a	  major	  technical	  step	  to	  be	  surpassed	  due	   to	   the	   fibrous	   nature	   of	   the	   tissue	   (mainly	   composed	   of	   connective	   tissue)	   and	  different	   methods	   to	   homogenize	   the	   samples	   and	   extract	   RNA	   were	   tested.	  Homogenization	   procedures	   using	   an	   electric	   homogenizer	   for	   5	   sec,	   a	   Piston	   RNA	  extraction	  method	  and	  homogenization	   in	   liquid	  nitrogen	  using	   a	  mortar	   and	  a	  pestle	  were	   assayed.	   The	   best	   method	   concerning	   RNA	   yield	   and	   integrity	   was	   the	  homogenization	  of	  the	  tissue	  in	  the	  liquid	  nitrogen	  with	  the	  mortar	  and	  pestle	  followed	  by	  the	  Trizol	  Reagent	  RNA	  extraction.	  	  	  
1.2.2.	  Total	  RNA	  extraction	  protocol	  Samples	  stored	  at	  -­‐80˚C	  were	  homogenized	  in	  liquid	  nitrogen	  to	  preserve	  RNA	  integrity,	  the	  homogenized	  tissue	  was	  incubated	  with	  TRIzol	  Reagent	  and	  the	  RNA	  extraction	  was	  proceed	  as	  described	   in	  the	  PureLink™	  RNA	  Mini	  Kit	  Protocol	   from	  Invitrogen.	  Briefly,	  the	   same	   volume	   of	   70%	   ethanol	   was	   added,	   the	   homogenized	   tissue	   sample	   was	  transferred	  to	  a	  spin	  column	  with	  collection	  tube	  and	  centrifuged	  for	  15	  min	  at	  12000	  g	  at	   4°C.	   The	   flow-­‐through	   was	   discarded	   from	   collection	   tube	   and	   the	   remained	  homogenized	  tissue	  was	  centrifuged.	  Afterwards,	  RNA	  was	  washed	  by	  adding	  700	  μl	  of	  wash	  buffer	  I	  and	  centrifuged	  for	  15	  sec	  at	  12000	  g	  at	  room	  temperature	  (RT).	  Filtrate	  was	  discarded	   and	   the	   spin	   column	  was	  placed	   into	   a	   fresh	   collection	   tube,	   then	  RNA	  was	   washed	   by	   adding	   500	   μl	   of	   diluted	   wash	   buffer	   II	   to	   the	   spin	   column	   and	  centrifuged	  for	  15	  sec	  at	  12000	  g.	  Filtrate	  was	  discarded	  and	  RNA	  was	  washed	  a	  second	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time	  by	  adding	  500	  μl	  of	  diluted	  wash	  buffer	  II	   to	  the	  spin	  column	  and	  centrifuged	  for	  further	   15	   sec	   at	   12000	   g.	   Filtrate	   was	   again	   discarded	   and	   then	   centrifuged	   for	   an	  additional	   1-­‐2	  min	   at	   12000	  g	   in	   order	   to	   dry	   the	  membrane	  with	   the	   attached	  RNA.	  Then	   the	   spin	   column	  was	   transferred	   to	   an	  RNAse	   free	   collection	   tube	   and	  RNA	  was	  eluted	  by	  adding	  30	  µl	  RNase	   free	  water.	  Finally,	  samples	  were	   incubated	   for	  1	  min	  at	  RT,	  centrifuged	  for	  2	  min	  at	  12000	  g	  and	  stored	  at	  -­‐80	  °C.	  
	  
1.2.3.	  	  RNA	  integrity	  and	  quantification	  RNA	   samples	   were	   quantified	   using	   the	   Thermo	   Scientific	   NanoDrop™	   1000	  Spectrophotometer,	   which	   measures	   1	   μl	   samples	   with	   high	   accuracy	   and	  reproducibility.	   	   Samples	   absorbance	   was	   read	   at	   260	   and	   280	   nm.	   The	   ratio	   of	  absorbance	  at	  260	  and	  280	  nm	  was	  used	  to	  assess	  the	  purity	  of	  RNA	  and	  usually	  a	  ratio	  between	  1,8	  and	  2,0	  is	  generally	  accepted	  as	  clean	  for	  RNA.	  Therefore,	  only	  the	  samples	  within	  this	  ratio	  gap	  were	  used	  in	  the	  study.	  The	  integrity	  and	  size	  distribution	  of	  total	  RNA	  was	  assessed	  by	  running	  RNA	  samples	  in	  a	  2%	  agarose	  gel.	  
	  
1.2.4.	  Reverse	  Transcription	  –	  Polymerase	  Chain	  Reaction	  (RT-­‐PCR)	  In	   molecular	   biology,	   RT-­‐PCR	   is	   a	   laboratory	   technique	   for	   amplifying	   a	   defined	  sequence	   of	   RNA	   molecule.	   The	   RNA	   strand	   is	   first	   reverse	   transcribed	   into	   its	  complementary	  DNA	  (cDNA),	  followed	  by	  amplification	  of	  the	  resulting	  DNA	  using	  PCR.	  	  First–strand	   cDNA	   synthesis	   was	   carried	   out	   using	   the	   SuperScriptTM	   First-­‐Strand	  Synthesis	   System	   for	   RT-­‐PCR.	   Briefly,	   500	   ng	   of	   total	   RNA	   and	   DEPC	   water	   in	   a	  combined	   volume	   of	   8	   μl,	   1	   μl	   of	   dNTPs	   mix	   (10mM)	   and	   1	   μl	   of	   oligomeric	   deoxy-­‐thimine	   nucleotides	   (0,5μg/ul)	   were	   added	   to	   each	   eppendorf	   tube	   (RNAse	   free)	   and	  were	  incubated	  for	  5	  min	  at	  65°C	  and	  chilled	  on	  ice	  for	  1	  min.	  After	  adding	  2	  μl	  of	  10X	  RT-­‐buffer	  (200	  mM	  Tris-­‐HCl	  (pH	  8.4),	  500	  mM	  KCl),	  4	  μl	  of	  MgCl2	  (25mM),	  2	  μl	  of	  DTT	  (0.1	  M),	  and	  1	  μl	  of	  RNase	  OUT	  to	  each	  eppendorf,	  the	  reaction	  was	  incubated	  for	  2	  min	  at	  42°C.	  Then	  it	  was	  added	  1	  μl	  of	  SuperScriptTM	  II	  reverse	  transcriptase	  II	  (50	  units/	  μl),	  and	   the	   reaction	   was	   incubated	   for	   1h	   at	   42°C.	   Finally,	   the	   reaction	   was	   ended	  incubating	  at	  70°C	  for	  15	  min.	  At	  the	  end	  of	  incubation	  time,	  1	  μl	  of	  RNAse	  H	  was	  added	  to	   each	   eppendorf	   and	   again	   incubated,	   at	   37°C	   for	   20	   min,	   therefore	   RNAse	   H	   can	  eliminate	  reminiscent	  RNA	  that	  has	  not	  been	  reverse	  transcripted.	  After	  the	  cDNA	  synthesis,	  a	  master	  mix	  was	  prepared,	  including	  2	  μl	  of	  forward	  (sense)	  primer	  (10	  mM),	  2	  μl	  of	  reverse	  (antisense)	  primer	  (10	  mM),	  2	  μl	  of	  dNTPs	  (10	  mM),	  1,5	  μl	   MgCl2	   (25	  mM),	   2,5	   μl	   of	   Taq	   buffer	   (10X),	   0.25	   μl	   Taq	   polymerase	   (5	   U/ml)	   and	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completing	  to	  25	  μl	  with	  sterile	  water	  for	  each	  tube,	  already	  containing	  2	  μl	  of	  the	  cDNA	  to	  be	  amplified.	  	  The	  following	  table	  presents	  the	  primer	  sequences	  and	  annealing	  temperatures	  for	  each	  studied	  gene:	  NPY,	  Substance	  P,	  IL-­‐6,	  IL-­‐1β,	  TNF-­‐	  α	  and	  B2M	  (as	  the	  housekeeping	  gene).	  	  
Table	  9.	  Primers	  




B2M	  Forward:	   5’	  –CCAGCGTACTCCAAAGATTCAG-­‐3’	   113	  bp	   58°C	  
B2M	  Reverse:	   3’	  –AGTCAACTTCAATGTCGGATGG-­‐	  5’	  
NPY	  Forward:	   5’-­‐	  CTGCGACACTACATCAACCT–	  3’	   100	  bp	   58°C	  
NPY	  Reverse:	   3’	  –TTTCTGTGCTTTCTCTCATCAAG-­‐	  5’	  
SP	  Forward:	   5’	  –CCTCAGCAGTTCTTTGGATTA-­‐	  3’	   128	  bp	   58°C	  
SP	  Reverse:	   3’	  –GCACTCCTTTCATAAGCCATT-­‐	  5’	  
IL-­‐6	  Forward:	   5’	  –CAATCTGGATTCAATGAGGAGACT-­‐	  3’	   89	  bp	   57°C	  
IL-­‐6	  Reverse:	   3’	  –CTGTTCTGGAGGTACTCTAGGTAT-­‐	  5’	  
IL-­‐1β	  Forward:	   5’	  –CTTCAGCCAATCTTCATT-­‐	  3’	   88	  bp	   55°C	  
IL-­‐1β	  Reverse:	   3’	  –CACTGTAATAAGCCATCAT-­‐	  5’	  
TNF-­‐α	  Forward:	   5’	  –TCTCTCTAATCAGCCCTCTG-­‐	  3’	   83	  bp	   58°C	  
TNF-­‐α	  Reverse:	   3’	  –TGCTACAACATGGGCTACAG-­‐	  5’	  	  The	  following	  termocycler	  program	  was	  used	  for	  all	  the	  samples:	  
Step	   T	  (°C)	   Time	   Number	  of	  Cycles	  1	   95°C	   5’	   	  2	   94°C	   1’	   	  3	   Tannealing*	   1’	   35	  x	  4	   72°C	   2’	   	  5	   72°C	   10’	   	  6	   4°C	   24h	   	  
*Tannealing	  for	  each	  gene	  is	  described	  on	  Table	  2	  
	  
1.2.5.	  Real-­‐Time	  Polymerase	  Chain	  Reaction	  The	  RNA	  extraction	  and	  cDNA	  synthesis	  was	  performed	  as	  described	  previously	  in	  1.2.2	  and	  1.2.4	   sections.	  A	  master	  mix	  of	   iQ	  SYBR	  Green	  (100	  mM	  KCl,	  40	  mM	  Tris-­‐HCl,	  pH	  8.4,	  0.4	  mM	  of	  each	  dNTP,	  iTaq	  DNA	  polymerase	  50	  units/mL,	  6mM	  MgCl2,	  SYBR	  Green	  I	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20	   nM	   fluorescein	   and	   stabilizers)	   supermix	   was	   prepared	   containing	   the	   primers,	  according	  to	  the	  following	  reaction	  setup:	  	  
Table	  10.	  Components	  and	  volume	  per	  reaction	  used	  for	  the	  iQ	  SYBR	  Green	  
master	  mix:	  
Component	   Volume	  per	  reaction	  iQ	  SYBR	  Green	  Supermix	   10	  μl	  Primer	  sense	  (10	  μM)	   0,25	  μl	  Primer	  anti-­‐sense	  (10	  μM)	   0,25	  μl	  Sterile	  water	   8,5	  μl	  
Total	  volume:	   19	  μl	  	  Afterwards,	  19	  μl	  of	  this	  master	  mix	  were	  added	  to	  each	  well	  and	  then	  1	  μl	  of	  the	  cDNA	  from	  each	  sample.	  At	   least	  3	  replicates	  of	  each	  cDNA	  sample	  were	  prepared.	  Then	   the	  plate	  was	  covered	  with	  a	  sealing	  film	  and	  read	  with	  real-­‐time	  PCR	  detection	  system	  (IQ5	  Multicolor	  Real-­‐time	  PCR	  detection	  System	   from	  Bio-­‐Rad	   (hercules,	  CA,	  USA),	  defining	  the	  melting	  and	  annealing	   temperatures	  according	   to	   the	  primer	  set.	  The	  results	  were	  treated	  using	  the	  Livak	  method.	  The	   Livak	   method	   assumes	   that	   both	   target	   and	   reference	   genes	   are	   amplified	   with	  efficiencies	  near	  100%	  and	  within	  5%	  of	  each	  other.	  For	  that	  reason,	  in	  the	  beginning	  it	  was	  made	  an	  optimization	  of	  the	  pattern	  curves	  for	  each	  primer,	  in	  order	  to	  determine	  the	  best	  conditions	  of	  primer	  and	  cDNA	  to	  use	  and	  confirm	  that	  the	  efficiency	  is	  between	  95%	  and	  105%.	  First,	  a	  mean	  is	  calculated	  between	  the	  3	  replicates	  for	  the	  reference	  gene	  and	  the	  target	  gene.	  The	  value	  of	  threshold	  cycle	  (CT)	  of	  the	  target	  gene	  is	  deducted	  to	  that	  of	  reference	  (ref)	  or	  housekeeping	  gene,	  for	  the	  test	  samples:	  ΔCT	  (sample)	  =	  CT	  (ref)	  –	  CT	  (target	  gene).	  	  Later,	  the	  expression	  ratio	  is	  considered	  by	  calculating	  the	  normalized	  expression:	  	  	  2-­‐ΔCT	  =	  normalized	  expression	  ratio	  	  The	   result	   obtained	   of	   the	   target	   gene	   in	   the	   sample	   is	   therefore	   normalized	   to	   the	  expression	  of	  a	  reference	  gene.	  Normalizing	  the	  expression	  of	  the	  target	  gene	  to	  that	  of	  the	  reference	  gene	  compensates	  for	  any	  difference	  in	  the	  amount	  of	  the	  sample	  cDNA.	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1.2.6.	  Agarose	  Gel	  Electrophoresis	  The	   integrity	   and	   size	  distribution	  of	   total	  RNA	  was	   assessed	  by	   running	  diluted	  RNA	  sample	  in	  a	  2%	  agarose	  gel.	  	  PCR	  products	  were	  loaded	  into	  a	  3,5%	  agarose	  gel.	  	  After	  cooling,	  10	  μl	  of	  ethidium	  bromide	  were	  added	  to	  the	  solution,	  homogenized	  and	  put	  onto	  gel	  tin	  to	  solidify.	  The	  conditions	  	  of	  the	  run	  were	  120	  V,	  150	  mA,	  60	  min,	  in	  the	  horizontal	  gel	  unit	  PowerPac	  Basic,	  from	  Bio	  Rad®.	  To	  scan	  the	  gel	  loaded	  with	  RT-­‐PCR	  products,	  Gel	  Doc™	  EZ	  System	  from	  BioRad®	  was	  used.	  	   	  	  
1.3	  Histological	  analysis	  
Immediately	   after	   surgery,	   tissues	   retrieved	   from	   capsule	   were	   fixed	   in	   3,7%	  formaldehyde	  at	  RT	  until	  processed.	  Samples	  were	  then	  dehydrated	  in	  an	  ethanol	  series	  for	   1h	   and	   embedded	   in	  paraffin	   and	   cut	   in	  3	   μm	   sections	   for	   susbsquent	  histological	  analysis.	  
	  
1.3.1.	  Hematoxylin	  /	  Eosin	  staining	  Sections	  were	   deparaffinized	   in	   xylene	   and	   hydrated	   in	   descending	   grades	   of	   ethanol	  (100%,	  96%,	  70%	  and	  50%)	  for	  3	  min,	  and	  then	  in	  water.	  Slides	  were	  incubated	  in	  Gill’s	  hematoxylin	  for	  3	  min,	  in	  distillated	  water	  for	  5	  min,	  in	  Eosin	  for	  2	  min	  and	  30	  sec	  and	  washed	   in	   distillated	   water	   again	   for	   3	   min.	   Afterwards,	   samples	   were	   hydrated	   in	  ascending	  grades	  of	  ethanol	  (50%,	  70%,	  96%	  and	  100%)	  for	  3	  min	  in	  each	  solution	  and,	  finally,	   sections	   were	   diaphanized	   in	   xylene	   and	   covered	   with	   coverslips	   using	   the	  mounting	   solution.	   Samples	   were	   visualized	   in	   an	   Olympus	   Optical	   Microscope	  (Olympus	  DP	  25	  Camera	  Software	  Cell	  B).	  	  
1.3.2.	  NPY	  and	  NF200	  Immunohistochemistry	  An	   immunohistochemistry	   assay	   was	   performed	   to	   detect	   NPY	   and	   NF200	   in	   serial	  slides	   for	   5	   Primary	   and	   5	   Revision	   Arthroplasties’	   samples.	   	   NF200	   stains	   for	  myelinated	  primary	  afferent	  sensory	  nerve	  fibers.	  Firstly,	  sections	  were	  deparaffinized	  in	  xylene,	  hydrated	  in	  a	  descendent	  series	  of	  ethanol	  solutions	  and	  washed	  3x	  in	  PBS	  for	  5	  min.	  Slides	  were	  incubated	  for	  5	  min	  in	  1%	  of	  Triton	  X-­‐100	  in	  order	  to	  permeabilize	  the	   cells	   and	   then	  washed	   3x	  with	   PBS	   for	   5	  min.	   Antigenic	   recovery	  was	   done	  with	  proteinase	  K	  at	  37°C	  during	  10	  min	  and	  stopped	  by	  washing	  5	  min	  with	  cold	  PBS	  (4°C).	  Next,	   sodium	  borohydride	  0,1%	   in	  Tris-­‐EDTA	   (pH	  8)	  was	   added	   to	   block	   endogenous	  fluorescence	  and	  washed	  with	  PBS	  followed	  by	  protein	  blocking	  with	  10%	  FBS/1%	  BSA	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in	  PBS	  for	  1h	  at	  RT.	  The	  anti-­‐NPY	  and	  anti-­‐NF200	  primary	  antibodies	  diluted	  (1:500)	  in	  10%	  FBS/	  1%	  BSA	  in	  PBS	  were	  added	  to	  serial	  slides	  and	  samples	  incubated	  overnight	  at	  4°C.	  For	   signal	  detection,	   samples	  were	  washed	  with	  PBS	  and	   incubated	  with	  Alexa	  Fluor	  568	  donkey	  anti-­‐mouse	  secondary	  antibody	   for	  NPY	  and	  Alexa	  Fluor	  647	  rabbit	  anti-­‐mouse	  secondary	  antibody	  for	  NF200	  (1:1000	  in	  10%	  FBS/1%	  BSA	  in	  PBS	  dilution)	  for	  1h	  at	  RT,	  protected	  from	  light.	  Again,	  samples	  were	  washed	  with	  PBS,	  mounted	  with	  Vectashield	  containing	  DAPI	  and	  coverslips	  were	  sealed	  with	  nail	  polish.	  As	  a	  negative	  control,	   the	  primary	  antibodies	  were	  omitted	  and	   the	  slides	  were	   incubated	  only	  with	  primary	  antibody	  dilution	  buffer.	  
	  
1.3.3.	   Macrophages	   distribution	   in	   Primary	   vs	   Revision	   Hip	  
Arthroplasties	  –	  CD68	  immunostaining	  An	   immunohistochemistry	   assay	   was	   performed	   to	   detect	   macrophages.	   Briefly,	  sections	   were	   deparaffinized,	   hydrated	   in	   a	   series	   of	   ethanol	   solutions	   (100%,	   96%,	  70%	   and	   50%)	   and	   washed	   in	   tap	   water.	   Antigen	   retrieval	   was	   performed	   with	  Tris/EDTA	   buffer	   in	   water	   bath.	   For	   that,	   water	   bath	   with	   a	   staining	   dish	   containing	  Tris-­‐EDTA	  buffer	  (pH	  9)	  was	  turned	  on	  until	  temperature	  reaches	  95-­‐100°C.	  Afterwards	  slides	  were	  immersed	  in	  the	  water	  bath	  for	  20	  min	  and	  then	  allow	  the	  slides	  to	  cool	  for	  20	   min	   at	   RT	   for	   another	   20	   min	   and	   washed	   in	   water.	   Hydrogen	   peroxide	   3%	   was	  added	  for	  10	  min	  and	  washed	  with	  PBS	  followed	  by	  protein	  blocking.	  The	  anti-­‐CD68,	  a	  marker	  for	  macrophages,	  primary	  antibody	  diluted	  (1:100)	  in	  primary	  antibody	  dilution	  buffer	  was	  added	  and	  samples	  incubated	  overnight	  at	  4°C.	  For	  signal	  detection,	  samples	  were	   washed	   with	   PBS	   and	   incubated	   with	   a	   biotinylated	   anti-­‐mouse	   secondary	  antibody	  (1:200,	   in	  secondary	  antibody	  dilution	  buffer),	   for	  30	  min	  at	  RT,	   followed	  by	  Streptavidin-­‐Biotin	  HRP	   Solution	   (1:100	   in	   secondary	   antibody	  dilution	  buffer)	   for	   30	  min.	  Again,	   samples	  were	  washed	  with	  PBS	  and	  developed	  with	  chromogenic	  DAB	   for	  10	  min.	  Finally,	  cells	  were	  washed	  in	  tap	  water	  and	  contrasted	  with	  Gill’s	  Hematoxylin	  for	   30	   sec,	   dehydrated	   in	   a	   series	   of	   ethanol	   solutions	   and	   diaphanized	   in	   xylene.	  Samples	   were	   fixed	   in	   histofluid	   solution	   and	   visualized	   with	   Olympus	   Optical	  Microscope	  (Olympus	  DP	  25	  Camera	  Software	  Cell	  B).	  As	  a	  negative	  control,	  the	  primary	  antibody	  was	  omitted.	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B.	   The	   effect	   of	   NPY	   system	   in	   the	   modulation	   of	  
cytokines	   on	   macrophages	   stimulated	   by	   Cobalt	  
Nanoparticles	  
	  
1.	  THP-­‐1	  cell	  line	  as	  a	  model	  for	  macrophages	  cultures	  THP-­‐1	   cells	   are	   a	   human	   monocytic	   leukemia	   cell	   line	   [132].	   Monocytic	   cell	   lines	   of	  different	  degrees	  of	  differentiation	  are	   frequently	  used	   to	  model	  macrophage	   function	  since	   primary	   tissue	   macrophages	   cannot	   be	   readily	   expanded	   ex	   vivo.	   There	   are	  different	  protocols	  for	  differentiation	  that	  varies	  with	  the	  differentiation	  treatment	  and	  duration	  [133].	  THP-­‐1	   is	  single	  and	  round	  suspension	  cells,	  however	  after	  exposure	  to	  phorbol-­‐12-­‐myristate-­‐13-­‐acetate	  (PMA)	  or	  1α,	  25-­‐dihydroxyvitamin	  D3	  [1α,25(OH)2D3],	  nearly	   all	   THP-­‐1	   cells	   start	   to	   adhere	   to	   culture	   plates	   and	   differentiate	   into	   a	  macrophage	  phenotype	  with	  evident	  morphological	  changes	  [133,	  134].	  However,	   PMA	   treatment	   leads	   to	   a	   more	   mature	   phenotype	   with	   higher	   levels	   of	  adherence	  and	  higher	  cell-­‐surface	  expression	  of	  macrophages	  markers	  like	  CD14	  [134],	  therefore,	  this	  was	  the	  protocol	  of	  differentiation	  chosen.	  	  	  
	  
1.1.	  Cell	  culture	  
The	   human	   monocytic	   leukemia	   cell	   line,	   THP-­‐1,	   was	   established	   by	   Tsuchiya	   et.	   al	  (1980)	  and	  has	  macrophage	  functions	  when	  differentiated	  [135].	  THP-­‐1	  monocytic	  cells	  acquired	  from	  Sigma-­‐Aldrich	  (reference	  88081201),	  were	  grown	  in	  RPMI	  1640	  medium	  supplemented	  with	  2mM	  Glutamine,	  10%	   inactivated	  FBS	  and	  1%	  P/S.	  The	  cells	  were	  maintained	  at	  37°C	  in	  humidified	  atmosphere	  of	  5%	  CO2.	  To	  induce	  the	  differentiation,	  serum	   free	  RPMI	   1640	  medium	   supplemented	  with	   2mM	  Glutamine	   and	   1%	  P/S	  was	  used	  with	  a	  stimulus	  of	  PMA.	  	  
1.1.1.	  Cell	  harvesting	  For	   maintenance	   of	   the	   cultures,	   cells	   were	   harvested	   twice	   to	   three	   times	   a	   week.	  Briefly,	   half	   of	   the	   cell	   suspension	   was	   discarded	   and	   the	   other	   half	   transferred	   into	  new-­‐labeled	  flask	  containing	  pre-­‐warmed	  medium	  or	  seeded	  onto	  6-­‐well	  culture	  plates	  to	   use	   in	   differentiation	   assays.	   Cells	   were	   maintained	   in	   the	   incubator	   at	   37°C,	   in	  humidified	  atmosphere	  of	  5%	  CO2.	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1.1.2.	  THP-­‐1	  cell	  line	  differentiation	  PMA	  treatment	  activates	  protein	  kinase	  C	  and	  induces	  a	  high	  degree	  of	  differentiation	  in	  THP-­‐1	   cells	   as	   reflected	   by	   increased	   adherence	   and	   expression	   of	   surface	   markers	  associated	  with	  macrophage	  differentiation	  [133].	  Different	  concentrations	  of	  PMA	  and	  different	   times	   of	   incubation	   with	   PMA	  were	   tested.	   200nM	   and	   400nM	   of	   PMA	  was	  tested	   for	   24h,	   48h	   and	   72h	   of	   incubation	   with	   cells.	   Afterwards,	   it	   was	   taken	   into	  account	  the	  number	  of	  cells	  that	  become	  adherent	  with	  these	  different	  conditions.	  	  
	  
1.1.3.	  Optimization	  of	  THP-­‐1	  cell	  line	  differentiation	  In	  addition	  to	  different	  concentrations	  of	  PMA	  and	  times	  of	  incubation	  it	  was	  also	  tested	  different	  cell	  densities	   in	  6-­‐well	  plates:	  2	  x	  105,	  5	  x	  105	  and	  1	  x	  106	  cells/well.	  Then	   it	  was	   assessed	   the	   expression	   of	   CD14	   in	   all	   conditions	   by	   flow	   cytometry.	   CD14	   is	   a	  differentiation	   marker,	   as	   it	   is	   highly	   expressed	   in	   macrophages	   when	   compared	   to	  monocytes.	  
	  
1.1.4.	   Flow	   Cytometry	   -­‐	   CD14	   as	   a	   marker	   of	   macrophage	  
differentiation	  	  A	   preliminary	   experiment	   using	   fluorescence-­‐activated	   cell	   sorting	   (FACS)	   was	  performed	   using	   CD14	   antibody,	   for	   assessment	   of	   CD14	   protein	   expression	   in	   the	  differentiated	  macrophages.	  Three	  days	  before	  starting	  this	  experiment,	  cells	  were	  centrifuged	  for	  3	  min	  at	  1200	  g	  and	   resuspended	   in	   medium	   without	   serum	   and	   supplemented	   with	   PMA	   200	   nM.	  Afterwards,	  cells	  were	  seeded	  upon	  glass	  coverslips	  in	  6-­‐well	  plate	  with	  a	  cell	  density	  of	  2	  x	  105,	  5	  x	  105	  and	  1	  x	  106	  cell	  per	  well	  and	  left	  undisturbed	  in	  the	  incubator	  for	  72h.	  The	   control	   cells	  were	   not	   exposed	   to	   any	   treatment	   in	   order	   to	   remain	   in	  monocyte	  phenotype.	  	  After	  72h,	  the	  differentiation	  was	  monitored	  by	  FACS.	  Plates	  were	  placed	  on	  ice	  and	  1	  ml	  of	   PBS-­‐EDTA	  was	   added	   to	   each	  well	   in	   order	   to	   detach	   the	   cells.	   After	   15-­‐20	  min,	   a	  scrapper	   was	   used	   to	   detach	   cells	   that	   remained	   in	   the	   coverslip.	   Cells	   were	   then	  transferred	  to	  centrifuge	  tubes	  and	  centrifuged	  for	  3	  min	  at	  1200	  rpm,	  resuspended	  in	  100	  μl	  of	  buffer	  X	  (Sodium	  Azide	  5%	  in	  PBS)	  and	  transferred	  to	  a	  96-­‐well	  plate	  U-­‐shape.	  Later	   on,	   cells	   were	   incubated	   for	   30	   min	   with	   monoclonal	   anti-­‐human	   CD14*PE	  antibody	   diluted	   in	   buffer	   X,	   protected	   from	   light.	   The	   cells	   used	   as	   negative	   controls	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were	   incubated	   with	   IGg1*PE	   instead	   of	   anti-­‐CD14.	   After	   incubation,	   the	   plate	   was	  centrifuged	   at	   1200	   g	   for	   3	   min	   at	   4°C	   and	   washed	   again	   twice	   with	   buffer	   X	   and	  resuspended	   in	   PBS	   1X.	   Finally,	   this	   solution	  was	   transferred	   to	   FACS	   flow	   tubes	   and	  acquired	  in	  FACScalibur®	  (Becton	  Dicksinson).	  Results	  were	  analyzed	  with	  the	  analysis	  software	  Flow	  Jo.	  
	  
2.	  Cobalt	  Nanoparticles	  exposure	  Cobalt	  nanoparticles	  (Co	  NPs)	  were	  acquired	  from	  US	  Research	  Nanomaterials,	  Inc.	  For	  use	   in	   the	   cell	   cultures,	   the	   particles	   (1mg)	   were	   wrapped	   in	   aluminum	   foil	   and	  sterilized	   by	   heat	   treatment	   at	   180˚C	   for	   4	   h	   to	   destroy	   contaminating	   endotoxin.	  Afterwards,	   particles	   were	   resuspended	   in	   culture	   medium	   without	   serum	   and	  sonicated	   for	   30	   sec	   to	   desegregate	   the	   particles	   that	   had	   clumped	   during	   the	   heat	  treatment.	  Then	  the	  appropriate	  dilutions	  were	  made	  for	  the	  several	  concentrations	  of	  particles	  in	  complete	  RPMI	  1640	  culture	  medium.	  	  Regarding	   the	   cell	   line,	   the	   human	   monocytic	   cell	   line	   THP-­‐1	   was	   differentiated	   into	  macrophages.	  For	  that,	  1	  x	  106	  cells	  were	  seeded	   in	  6	  well	  plates	  with	  glass	  coverslips	  with	  2	  ml	  of	  RPMI	  1640	  serum-­‐free	  medium	  supplemented	  with	  200	  nM	  PMA	  for	  72	  h.	  After	  incubation,	  nonattached	  cells	  were	  removed	  by	  aspiration,	  and	  the	  adherent	  cells	  were	   washed	   three	   times	   with	   RPMI	   supplemented	   with	   FBS.	   Macrophage	   adherent	  cells	  were	  then	  exposed	  to	  0–20ppm	  of	  Co-­‐NPs	  (0,	  5,	  10,	  20	  ppm)	  for	  12h,	  24h	  and	  36h	  (Figure	  11.).	  Macrophages	  without	  NPs	  were	  used	  as	  control	  cells	  for	  every	  condition.	  Incubations	   were	   conducted	   at	   37˚C	   in	   a	   5%	   CO2	   environment.	   Triplicates	   were	  prepared	   for	   each	   condition.	   The	   resulting	   adherent	   cells	   were	   collected	   for	   mRNA	  expression	   tests	   and	   frozen	   at	   -­‐80˚C	   and	   also	   for	   viability/survival	   studies	   (Live/dead	  assay).	   Metabolic	   Activity	   studies	   (Alamar	   Blue	   assay)	   were	   also	   conducted	   for	   each	  condition.	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Figure	  11.	  Representative	  diagram	  of	  the	  cell	  culture	  experiments.	  For	  each	  plate	  it	  was	  assessed	  
NPY	  receptors	  and	  cytokines	  mRNA	  expression	  levels,	  metabolic	  activity	  and	  viability	  at	  12h,	  24h	  
and	  36h	  of	  incubations	  with	  Co-­‐NPs.	  
	  
2.1.	  Metabolic	  Activity	  –Alamar	  Blue	  ™	  assay	  
The	  AlamarBlue	  Assay	  incorporates	  a	  fluorometric/colorimetric	  growth	  indicator	  based	  on	   detection	   of	   metabolic	   activity.	   Specifically,	   the	   system	   incorporates	   an	   oxidation-­‐reduction	   indicator	   that	   both	   fluoresces	   and	   changes	   color	   in	   response	   to	   chemical	  reduction	  of	  growth	  medium	  resulting	  from	  cell	  growth.	  Briefly,	  200	  µl	  of	  resazurin	  was	  added	   to	   each	   well	   that	   already	   contained	   2ml	   of	   complete	   RPMI	   and	   was	   left	  undisturbed	  in	  the	  incubator	  for	  2	  hours.	  As	  a	  negative	  control,	  resazurin	  was	  added	  to	  complete	   RPMI	   medium	   without	   cells	   and	   it	   was	   left	   in	   the	   same	   conditions.	   After	  incubation,	  200	  µl	  of	   the	  media	  of	  each	  well	  was	  collected	   to	  96	  black	  well	  plates	  and	  three	  replicas	  were	  used	  for	  each	  well.	  The	  results	  were	  obtained	  colorimetrically	  at	  570	  nm	  with	  normalization	  of	  interference	  at	  600nm	  using	  a	  micro-­‐plate	  spectrophotometer	  (Biotek	  Plate	  Reader	  Synergy	  MX).	  The	   results	  were	  expressed	  as	  a	  percent	  of	   control	  values	   (fresh	   RPMI	   without	   cells).	   Afterwards,	   all	   the	   media	   from	   each	   well	   was	  discarded	  and	  cells	  were	  washed	  with	  PBS	  to	  proceed	  with	  Live/Dead	  assay.	  	  
2.2.	  	  Live/Dead	  assay	  
Cells	  were	  washed	  with	  PBS	  3x,	  followed	  by	  RPMI	  1640	  medium	  without	  serum.	  Calcein	  AM	   solution	   at	   1µM	   of	   concentration	   in	   RPMI	   1640	   without	   serum	   was	   added.	  Afterwards,	  plates	  were	  incubated	  for	  30	  min	  at	  37°C	  and	  10µL	  of	  ethidium	  homodimer-­‐1	   (EthD-­‐1)	   at	   5mM	   was	   added	   to	   cells,	   which	   were	   then	   visualized	   by	   fluorescence	  microscopy	  (Zeiss	  Axio	  Imager	  Z1	  microscope).	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2.3.	  Y	  receptors	  and	  cytokines	  mRNA	  expression	  
2.3.1.	  RNA	  extraction	  Macrophages	  were	  incubated	  with	  700µl	  of	  Tri-­‐Reagent/well	  for	  5	  minutes	  at	  RT.	  Then	  cells	  were	   resuspendedand	   collected	   in	   1,5ml	  microtubes,	   kept	   at	   -­‐80°C	  until	   proceed	  with	  RNA	  extraction	  according	  to	  what	  is	  described	  in	  1.2.2.	  
	  
	   2.3.2.	  RT-­‐Polymerase	  Chain	  Reaction	  (primers)	  	  Y1,	  Y2	  and	  Y5	  receptors,	  NPY,	  Substance	  P,	  IL-­‐6,	  TNF-­‐	  α	  and	  IL-­‐1β	  mRNA	  expression	  was	  assessed	  by	  PCR	  for	  all	  the	  conditions	  as	  described	  in	  section	  1.2.5.	  The	  RT-­‐PCR	  reaction	  was	  performed	  as	  described	  previously,	  in	  1.2.5,	  with	  the	  sets	  of	  primers	  for	  human	  Y1,	  Y2	  and	  Y5	  receptors,	  NPY,	  Substance	  P,	  IL-­‐6,	  TNF-­‐	  α	  and	  IL-­‐1	  β	  and	  B2M	  (presented	  on	  
Table	  11).	  	  The	  same	  termocycler	  program	  as	  described	  previously,	   in	  section	  1.2.4.,	  was	  used	  for	  all	  the	  samples,	  with	  annealing	  temperatures	  described	  on	  Table	  9	  and	  Table	  11.	  Gene	  expression	  semi-­‐quantification	  was	  measured	  comparing	  the	  expression	  of	  target	  genes	  with	   the	   housekeeping	   gene,	   B2M,	   using	   ImageQuant	   Software.	   This	   comparison	   is	  performed	  to	  normalize	  the	  amount	  of	  RNA	  used	  for	  all	  the	  samples.	  	  	  
Table	  11.	  Y1,	  Y2	  and	  Y5	  receptors	  primer	  sequence,	  product	  size	  and	  annealing	  
temperature	  
	  




Y1	  Forward:	   5’	  –AAGAGGATTGTTCAGTTCA-­‐	  3’	   154	  bp	   55°C	  
Y1	  Reverse:	   3’	  –GATTGGTTTGGTTGTTATAGA-­‐	  5’	  
Y2	  Forward:	   5’	  –ACTCTTACCTATACCTTAATG-­‐	  3’	   101	  bp	   58°C	  
Y2	  Reverse:	   3’	  –GTGATTGTGGATACTTGT-­‐	  5’	  
Y5	  Forward:	   5’	  –AAGGAAGGGAAAGGGTGTTAC-­‐	  3’	   162	  bp	   58°C	  
Y5	  Reverse:	   3’	  –CGAGTGGCAGCAGTATTATTCT-­‐	  5’	  
	  
3.	  Statistical	  analysis	  Data	   analysis	   was	   performed	   by	   Student’s	   t-­‐test	   or	   One-­‐Way	   ANOVA	   followed	   by	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Newman-­‐Keuls	   post-­‐hoc	   test.	   Statistical	   analysis	   was	   performed	   using	   the	   Graphpad	  v5.0.	  p-­‐value<0.05	  was	  considered	  statistically	  significant.	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A.	   Neuropeptides	   and	   Pro-­‐inflammatory	  
Cytokines	   expression	   in	   patients	   undergoing	  
Primary	  and	  Revision	  Hip	  Arthroplasties	  	  	  
1.1.	  Samples	  Collection	  With	  the	  purpose	  of	  evaluating	  the	  role	  of	  NPY	  and	  the	  peripheral	  nervous	  system	  in	  the	  modulation	   of	   the	   inflammatory	   process	   associated	   with	   human	   hip	   arthroplasties	   a	  protocol	   for	   sample	   collection	   was	   defined	   and	   asked	   to	   be	   filled	   by	   the	   hospitals	  associated	   with	   this	   study,	   at	   the	   time	   of	   surgery	   (see	   section	   1.1.	   in	   Material	   and	  
Methods).	  	  So	  far	  we	  were	  able	  to	  collect	  15	  cases	  of	  primary	  arthroplasty	  and	  15	  cases	  of	  revision	  arthroplasty,	  all	  retrieved	  from	  capsule.	  	  With	  the	  information	  given	  by	  questionnaires,	  we	  found	  that	  the	  main	  cause	  of	  primary	  arthroplasty	  intervention	  was	  OA	  (11	  out	  of	  15	  patients)	  and	  the	  main	  cause	  for	  revision	  arthroplasty	   intervention	   was	   osteolysis	   and	   pain	   (8	   out	   of	   15	   patients).	   The	   age	  distribution	  is	  presented	  in	  Figure	  12.	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13.).	   Similarly,	   in	   revision	  arthroplasty	   (Figure	   14.)	   a	  higher	  number	  of	  women	  were	  affected	  in	  our	  samples.	  
	  
Figure	  13.	  Gender	  and	  Age	  distribution	  in	  Primary	  arthroplasties	  (n=12).	  
	  
Figure	  14.	  Gender	  and	  Age	  distribution	  in	  Revision	  arthroplasties	  (n=11).	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1.2.	   mRNA	   expression	   of	   NPY,	   Substance	   P	   and	   Pro-­‐
inflammatory	  Cytokines	  (IL-­‐6,	  TNF-­‐α	  and	  IL-­‐1β)	  	  Since	  it	  is	  known	  that	  immune	  system	  and	  nervous	  system	  interact	  with	  each	  other,	  we	  decided	   to	   investigate	   the	   role	   of	   NPY	   and	   SP	   in	   cytokines	   recruitment	   in	   the	   hip	  arthroplasty	  model.	  Previous	   studies	   have	  measured	   some	  mediators	   secreted	   by	   hip	   synovial	  membrane,	  but	   so	   far,	   no	   correlation	   between	   the	   NPY	   system	   and	   the	   inflammatory	   process	  associated	   with	   hip	   replacement	   surgery	   was	   determined.	   With	   the	   purpose	   of	  investigating	  such	  a	  putative	  correlation,	  we	  started	  by	  analyzing	  the	  mRNA	  expression	  levels	  of	  NPY,	  SP,	  and	   the	  cytokines	   IL-­‐6,	  TNF-­‐α	  and	   IL-­‐1β	  were	  assayed	  by	  Real	  Time	  PCR	   in	   samples	   isolated	   from	   15	   samples	   of	   primary	   and	   revision	   hip	   arthroplasties.	  These	  cytokines	  were	  selected	  since	  they	  are	  related	  to	  the	  pathogenesis	  of	  OA	  and	  bone	  resorption	   [56].	   In	   fact,	   there	   have	   been	   numerous	   reports	   relating	   the	   histological	  characteristics	   of	   the	   tissue	   at	   the	   bone–implant	   interface.	   Some	   of	   these	   studies	  demonstrated	   that	   tissues	   surrounding	   failed	   total	   hips	   arthroplasties	   produce	   pro-­‐inflammatory	  cytokines	  such	  as	   IL-­‐1	  and	   IL-­‐6	   that	  are	  capable	  of	   inducing	  osteoclastic	  bone	  resorption	  [139,	  140].	  Also,	  it	  was	  described	  that	  elevated	  levels	  of	  cytokines,	  such	  as	   IL-­‐1β	   and	   TNF-­‐α,	   powerful	   regulators	   of	   inflammation,	   were	   found	   early	   in	   the	  disease	  process	   [139].	  There	   is	   compelling	  evidence	   that	   inflammatory	   cytokines	   such	  as	   TNF-­‐α,	   IL-­‐1β	   and	   IL-­‐6	   can	   be	   secreted	   by	   synoviocytes,	   mononuclear	   cells	   in	   the	  synovial	  layer	  and	  by	  chondrocytes,	  disrupting	  cartilage	  homeostasis	  and	  facilitating	  the	  progressive	   metalloproteinase-­‐mediated	   digestion	   of	   cartilage	   matrix	   in	   OA	   [141].	  Furthermore,	  some	  studies	  have	  described	  the	  presence	  of	  TNF-­‐α	  in	  OA	  as	  a	  key	  factor	  in	  the	  cellular	  cascade	  that	  leads	  to	  bone	  resorption	  [142].	  	  As	  in	  the	  present	  study,	  Nabae	  et	  al.	  also	  measured	  the	  expression	  levels	  of	  several	  pro-­‐inflammatory	   cytokines,	   not	   in	   the	   fibrous	   capsule	   like	   us,	   but	   in	   the	   interfacial	  membrane	  at	   the	   time	  of	   revision	  surgery	   for	  aseptic	   loosening	  of	   implants	  and	   in	   the	  synovial	  tissue	  from	  osteoarthritic	  patients	  describing	  that	  IL-­‐1β	  was	  highly	  expressed	  in	  the	  interface	  membrane	  [142].	  	  Both	   the	  neuropeptides	   (NPY	  and	  SP)	  and	   the	  cytokines	   (IL-­‐6,	  TNF-­‐α	  and	   IL-­‐1β)	  were	  found	  to	  be	  expressed	  in	  our	  samples	  but	  at	  a	  low	  level	  (Figure	  15	  and	  16.).	  This	  result	  was	   expected	   since	   low	  expression	   levels	   of	   these	   cytokines	  were	   already	   reported	   in	  serum	  from	  patients	  with	  osteolysis	  [143].	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1.2.1.	  Primary	  arthroplasties	  
Regarding	   the	   cytokines	   expression	   in	   primary	   arthroplasties	   (Figure	   15.),	   it	   was	  verified	   a	   significant	   increase	   of	   TNF-­‐α	   comparing	   to	   the	   other	   pro-­‐inflammatory	  cytokines	  such	  as	  IL-­‐6	  and	  IL-­‐1β.	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
	  
Figure	   15.	   Normalized	   mRNA	   expression	   levels	   of	   NPY,	   SP,	   TNF-­‐α,	   IL-­‐6	   and	   IL-­‐1β	   in	   primary	  
arthroplasty	   samples	   (n=15).	   TNF-­‐α	   is	   significant	   increased	   compared	   with	   the	   other	   cytokines.	  
Resuls	   are	   reported	   as	  mean	  ±SEM.	   Significant	  differences	  between	  groups	   are	   represented	  as:	   **	  
p<0,01;	  ***	  p<	  0,001.	  The	  data	  was	  analyzed	  by	  one-­‐way	  ANOVA	  followed	  by	  Newman-­‐Keuls	  post-­‐hoc	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catabolic	   genes,	   colocalizes	   with	   TNF-­‐α,	   which	   drives	   the	   inflammatory	   process,	   and	  several	  MMPs	  in	  locals	  of	  matrix	  depletion	  in	  OA	  cartilage	  [145].	  	  	  The	   subsequent	   inflamed	   synoviocytes,	   chondrocytes	   and	   inflammatory	   cells	   such	   as	  macrophages	   can	   cause	   excessive	   release	   of	   cytokines,	   oxygen	   free	   species	   and	  neuropeptides	  from	  the	  nerve	  fibers	  to	  the	  synovial	  fluid	  and	  the	  tissue	  surrounding	  can	  shows	  signs	  of	  its	  depletion	  [146].	  	  In	   our	   results	  we	  observed	   that	  TNF-­‐α	   is	   the	  most	   expressed	   cytokine	   in	   primary	  hip	  arthroplasties.	  	  
	   1.2.2.	  Revision	  arthroplasties	  










Figure	   16.	   Normalized	   mRNA	   expression	   levels	   of	   NPY,	   SP,	   TNF-­‐α,	   IL-­‐6	   and	   IL-­‐1β	   in	   revision	  
arthroplasty	  samples	  (n=15).	  No	  significant	  diferences	  were	  found	  between	  cytokines	  and	  between	  
neuropeptides.	   There	   is	   a	   trend	   to	   the	   increase	   of	   TNF-­‐α	   with	   the	   other	   cytokines.	   Resuls	   are	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It	  has	  been	  suggested	   that,	  because	   the	   interfacial	  membrane	   is	   capable	  of	   releasing	  a	  variety	   of	   inflammatory	   mediators,	   this	   granulomatous	   tissue	   that	   includes	  macrophages,	  fibroblasts,	  and	  foreign	  body	  giant	  cells,	  must	  secrete	  factors	  that	  directly	  or	  indirectly	  participate	  in	  the	  bone	  resorption	  process	  and	  influence	  implant	  loosening	  [57,	  148].	  	  Regarding	  the	  neuropeptides	  expression,	  again	  low	  levels	  of	  NPY	  and	  SP	  were	  found	  in	  capsule	  samples	  (Figure	  16.).	  In	  an	  attempt	  to	  establish	  a	  correlation	  between	  inflammation	  and	  nervous	  system,	  we	  proceeded	   with	   a	   comparison	   between	   the	   two	   surgeries	   in	   order	   to	   observe	   the	  differences	  of	  expression	  levels	  of	  TNF-­‐α,	  IL-­‐1β,	  IL-­‐6,	  NPY	  and	  SP	  between	  primary	  and	  revision	  arthroplasties.	  	  	  	  
	   1.2.3.	  TNF-­‐α	  expression	  levels	  
The	  expression	  levels	  of	  TNF-­‐	  α	  in	  primary	  versus	  revision	  arthroplasties	  are	  present	  in	  
Figure	  17.	  Although,	  there	  were	  no	  significant	  differences	  between	  the	  two	  groups,	  the	  expression	   levels	   in	   primary	   arthroplasties	   are	   apparently	   higher	   than	   in	   revision	  arthroplasties.	  	  
	  
Figure	   17.	   TNF-­‐α	   expression	   levels	   in	   capsule	   from	   primary	   arthroplasties	   and	   revision	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Although	   the	  histopathology	  of	  bone	  resorption	   in	  OA	  and	  osteolysis	  are	  different,	   the	  tissue	  reaction	  to	  an	  implant	  resembles	  the	  inflammatory	  scenario	  of	  OA	  in	  its	  tendency	  to	  produce	   localized	   cytokine-­‐mediated	  bone	   loss	   [149].	  According	   to	   this,	   our	   results	  showed	  similar	  expression	  levels	  of	  TNF-­‐α	  in	  the	  two	  groups	  (Figure	  17.).	  
	  
1.2.4.	  IL-­‐1β	  expression	  levels	  
In	  Figure	   18.	   is	  present	   the	  mRNA	  expression	   levels	  of	   IL-­‐1β	   in	  primary	  and	   revision	  arthroplasties.	  Similarly	  to	  TNF-­‐α,	   the	  expression	   levels	   in	  primary	  arthroplasties	  tend	  to	  be	  slightly	  higher	  than	  in	  revision	  arthroplasties.	  	  
	  
	  
Figure	   18.	   	   IL-­‐1β	   expression	   levels	   in	   capsule	   from	   primary	   arthroplasties	   and	   revision	  
arthroplasties	  (n=15).	  No	  significant	  differences	  were	  found	  between	  the	  two	  groups	  (Student’s	  t-­‐
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expressed	   in	   interface	   membranes	   of	   aseptic	   loosened	   implants	   compared	   with	  osteoarthitic	   ones.	   On	   the	   other	   hand,	   Granchi	   et	   al.	  did	   not	   find	   a	   difference	   in	   IL-­‐1	  when	  comparing	  loosened	  hip	  arthroplasty	  to	  healthy	  controls	  [152].	  	  
	   1.2.5.	  IL-­‐6	  expression	  levels	  








Figure	  19.	  IL-­‐6	  expression	  levels	  in	  capsule	  from	  primary	  arthroplasties	  and	  revision	  arthroplasties	  
(n=15).	  No	  significant	  differences	  were	  found	  between	  the	  two	  groups	  (Student’s	  t-­‐test)	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1.2.6.	  Neuropeptides	  expression	  levels	  
It	  is	  known	  that	  the	  peripheral	  sensory	  nervous	  system	  contributes	  to	  the	  development	  of	   acute	   and	   chronic	   inflammatory	   processes	   through	   local	   release	   of	   neuropeptides	  [155].	   Taking	   this	   into	   account	  we	   decided	   to	   explore	   the	   role	   of	   NPY	   and	   SP	   in	   two	  different	   inflammatory	   situations	   (OA	   versus	   osteolysis)	   in	   order	   to	   see	   if	   these	  neuropeptides	   can	   contribute	   or	   cooperate	   with	   inflammatory	   cytokines	   and	   trigger	  aseptic	  loosening/osteolysis.	  Previous	  studies	  have	  already	  found	  autonomic	  neuropeptides	  in	  the	  synovium.	  Ahmed	  
et	  al	  has	  shown	  that	  the	  interface	  membrane	  in	  aseptic	  loose-­‐cemented	  hip	  prostheses	  is	  supplied	  by	  sensory	  nerve	   fibers	   immunoreactive	   to	  SP	   [109].	  Also,	  another	  study	  has	  shown	   that	   SP-­‐immunoreactive	   nerve	   fibers	   have	   also	   been	   detected	   in	   the	  pseudocapsular	  tissues	  around	  loose	  prostheses	  [106].	  However,	  as	  far	  as	  we	  are	  concerned,	  no	  study	  has	  ever	  compared	  the	  expression	  levels	  of	  neuropeptides	  in	  primary	  versus	  revision	  arthroplasties.	  	  
	   1.2.6.1.	  	  NPY	  expression	  levels	  In	   case	   of	   NPY	   expression	   levels,	   it	   is	   observed	   a	   trend	   to	   the	   increase	   in	   revision	  arthroplasties	  when	  compared	  to	  primary	  arthroplasties,	  as	  presented	  in	  Figure	  20.	  	  
	  
Figure	  20.	  NPY	  expression	  levels	  in	  capsule	  from	  primary	  arthroplasties	  and	  revision	  arthroplasties	  
(n=15).	  No	  significant	  differences	  were	  found	  between	  the	  two	  groups	  (Student’s	  t-­‐test).	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joint	   synovial	   fluid	   from	   patients	   with	   RA	   and	   suffering	   from	   pain	   showed	   high	  concentrations	  of	  NPY	  and	  CGRP,	  indicating	  that	  the	  nervous	  system	  is	  playing	  a	  role	  in	  the	  pathophysiological	  process	  [157].	  Relatively	   to	  revision	  arthroplasties,	  our	  hypothesis	   is	   that	   these	  expression	   levels	  are	  compatible	  with	   a	   reaction	   to	   the	   implant.	  Mutual	   regulation	  may	   occur	   betwwen	   the	  local	   release	   of	   neuropeptides	   into	   the	   joint	   tissue	   and	   the	   release	   of	   inflammatory	  cytokines,	  which	  may	   contribute	   to	  bone	   loss.	  The	   three	  patients	   that	  have	   the	  higher	  levels	   of	   NPY	   expression	   in	   revision	   arthroplasties	   suffered	   from	   pain	   and	   were	   all	  female	   and	   older	   than	   75	   years	   old,	   suggesting	   a	   possible	   correlation	   between	   NPY	  response	  and	  gender	  in	  this	  disease.	  	  	  
	   1.2.6.2.	  Substance	  P	  expression	  levels	  Contrary	   to	   NPY,	   the	   expression	   levels	   of	   SP	   have	   a	   tendency	   of	   increase	   in	   primary	  arthroplasties	  than	  in	  revision	  arthroplasties	  (Figure	  21.).	  SP	   has	   recognized	   pro-­‐inflammatory	   properties,	   augmenting	   the	   proliferation	   of	  rheumatoid	   synoviocytes	   and	   inducing	   the	   release	   of	   the	   proinflammatory	  mediators	  such	  as	  prostaglandin	  E2	  [158].	  The	  upregulation	  of	  SP	  in	  response	  to	  arthritis	  suggests	  a	  mechanism	  involving	  neuropeptides	  in	  the	  maintenance	  of	  a	  painful	  degenerative	  joint	  disease	   and	   in	   mediating	   noxious	   stimuli	   from	   the	   periphery.	   Furthermore,	   these	  findings	  help	  to	  explain	  clinical	  observations	  that	  are	  found	  in	  the	  questionnaires,	  such	  as	  a	  higher	  acute	  pain	  in	  primary	  arthroplasties.	  	  
	  
Figure	   21.	   Substance	   P	   expression	   levels	   in	   capsule	   from	   primary	   arthroplasties	   and	   revision	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  In	   this	   approach,	   the	   capsule	   levels	   of	   these	   cytokines	   and	   neuropeptides	   in	   primary	  surgery	  patients	  were	  used	  as	   controls	   versus	   those	  of	   revision	   surgery.	  No	   statistical	  significance	   was	   found	   between	   the	   two	   groups;	   however,	   trends	   were	   found.	   It	   is	  observed	   a	   trend	   to	   the	   increase	   of	   NPY	   and	   IL-­‐6	   in	   revision	   arthroplasties	   when	  compared	  with	  primary	  arthroplasties.	  On	   the	  other	  hand,	   it	  was	   found	  a	   trend	   to	   the	  increase	  of	  SP	  in	  primary	  arthroplasties.	  A	  higher	  number	  of	  patients	  is	  needed	  in	  order	  to	  complete	  and	  support	  our	  results,	  and	  achieve	  more	  elucidative	  conclusions	  with	  the	  information	  given	  by	  the	  questionnaires.	  In	   the	   context	   of	   revision,	   the	   fact	   that	   IL-­‐6	   and	   NPY	   were	   higher	   compared	   with	  primary	   surgery	  may	   indicate	   that	   these	   genes	   expression	   levels	   were	   related	   to	   the	  presence	  of	  the	  prosthesis	  in	  terms	  of	  material	  properties	  and	  mechanical	  factors.	  	  Il-­‐6	  was	  the	  cytokine	  with	  the	  lowest	  expression	  level	  in	  the	  capsule.	  One	  possibility	  for	  this	  to	  occur	  is	  that	  the	  continuous	  stimulation	  of	  macrophages	  by	  wear	  debris	  may	  over	  stimulate	  the	  IL-­‐6	  mechanism	  and	  contribute	  to	  the	  elevation	  of	  IL-­‐1	  secretion.	  	  In	  conclusion,	  many	  cells	  from	  periprosthetic	  tissue	  can	  secrete	  different	  mediators	  with	  potential	   bone-­‐resorbing	   activities.	   The	   pathophysiology	   of	   aseptic	   loosening	   is	  complex,	   and	   neuropeptides	   or	   cytokines	   are	   not	   the	   exclusively	   responsible	   for	   the	  progress	  of	  implant	  loosening.	  	  If	   these	   results	   are	   found	   to	   be	   statistically	   significant,	   it	   may	   indicate	   that	   these	  cytokines	  and	  neuropeptides	  can	  interact	  in	  a	  complex	  cascade	  and	  possibly	  constitute	  a	  target	   to	   treat	   or	   prevent	   osteolysis.	   If	   so	   we	   propose	   that	   neuropeptides	   may	  participate	   in	   inflammation	   indirectly,	   via	   a	   paracrine	   and	   autocrine	   action	   on	   the	  immunoregulatory	   cells.	   Additional	   research	   is	   necessary	   to	   clarify	   this	   cellular	   and	  molecular	   cascade	   and	   improve	   our	   understanding	   of	   the	   complex	   cytokine-­‐neuropeptides	  interactions	  associated	  to	  osteolysis.	  	  	  
1.3	  NPY	  and	  NF200	  expression	  by	  Immunohistochemistry	  Since	  expression	  of	  NPY	  was	  verified	  in	  tissue	  samples,	  and	  it	  is	  known	  to	  be	  released	  by	  sympathetic	  fibers,	  immunohistochemistry	  studies	  were	  performed	  to	  identify	  NPY	  and	  nerve	  fibers	  (NF200)	  in	  tissues	  retrieved	  from	  capsule	  from	  Primary	  and	  also	  Revision	  Arthroplasties.	   Five	   cases	   of	   Primary	   and	   five	   cases	   of	   Revision	   Arthroplasties	   were	  randomly	  used	  for	  the	  immunohistological	  analysis.	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Figure	  22.	  NPY	  and	  NF200	  immunostaining	  in	  Primary	  and	  Revision	  Artroplasty	  Samples.	  A,	  B	  and	  C	  
represent	  primary	  arthroplasty	  samples	  and	  D,	  E	  and	  F	  represent	  revision	  arthroplasty	  samples:	  A,	  
B,	   D	   and	   E	   are	   stained	   with	   NPY.	   C	   and	   F	   are	   negative	   controls.	   G,	   H	   and	   I	   represent	   primary	  
arthroplasty	   samples	   and	   J,	   K	   and	   L	   represent	   revision	   arthroplasty	   samples:	   G,	   H,	   J	   and	   K	   are	  
stained	  with	  NF200.	  I	  and	  L	  are	  negative	  controls.	  Scale	  bars	  25	  μm.	  	  In	   all	   primary	   and	   revision	   arthroplasty	   samples,	   NPY	   and	   NF200-­‐immunoreactive	  fibers	  were	  identified.	  No	  differences	  between	  the	  two	  groups	  were	  found.	  	  The	  nerve	  fibers	  were	  found	  to	  be	  arranged	  mainly	  around	  blood	  vessels	  (Figure	  22.	  B,	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B.	   Macrophages	   distribution	   in	   primary	   versus	  
revision	  hip	  arthroplasties	  
	  
1.	  Macrophages	  distribution	  After	  measuring	   the	   expression	   levels	   of	   several	   cytokines	   and	   neuropeptides,	   it	   was	  verified	   that	   TNF-­‐α	   was	   the	   most	   expressed	   cytokine	   in	   both	   primary	   and	   revision	  arthroplasties.	  TNF-­‐α	  is	  a	  cytokine	  that	  is	  mostly	  produced	  by	  macrophages/monocytes	  compared	  with	  IL-­‐1	  and	  IL-­‐6,	  which	  are	  secreted	  by	  a	  wider	  variety	  of	  cell	  types	  [144]	  and	  as	  our	  samples	  are	  from	  synovial	  membrane	  it	  is	  plausible	  that	  macrophages	  are	  the	  most	  abundant	  cells	  of	  our	  samples,	  therefore	  justifying	  the	  prevalence	  of	  TNF-­‐α.	  Several	  studies	  have	  reported	  that	  the	  synovial	  membrane	  has	  an	  increased	  number	  of	  macrophages	   [160].	  Also,	  macrophages	  may	  play	  an	   important	   role	   in	  osteolysis	   since	  they	  can	  phagocyte	  debris	  resulted	  from	  prosthesis	  wear	  [161].	  Taken	   this	   into	   account,	   we	   tried	   to	   investigate	   the	   effects	   of	   wear	   debris	   in	  macrophages	   distribution.	   For	   that,	  macrophages	  were	   stained	  with	   CD68,	   a	   common	  marker	   for	   macrophages,	   in	   samples	   retrieved	   from	   5	   different	   primary	   arthroplasty	  patients	  and	  5	  revision	  arthroplasty	  patients	  in	  order	  to	  confirm	  if	  there	  was	  a	  pattern	  between	  the	  two	  conditions.	  	  A	   clear	   difference	   between	   the	  macrophages	   distribution	   in	   these	   two	   conditions	  was	  observed	   (Figure	   23.).	   In	   all	   primary	   arthroplasty	   cases	   (OA)	   it	   was	   verified	   the	  appearance	  of	  a	  thick	  lining	  layer	  of	  cells	  in	  the	  border	  areas	  of	  the	  tissue	  (Figure	  23	  A,	  
B	  and	  C).	  Synovial	  membrane	  appeared	  normal	  in	  all	  cases,	  with	  no	  significant	  cellular	  reaction,	  such	  as	  cell	  infiltrates,	  and	  no	  increase	  in	  the	  thickness	  of	  the	  intimae	  cell	  layer.	  Other	   studies	   have	   previously	   characterized	   the	   synovial	   membrane	   in	   osteoarthritis	  [162-­‐164].	  Supporting	  our	  results,	  Roy	  et	  al	  [163]	  reported	  that	  the	  synovial	  membrane	  in	   osteoarthritis	   shows	   a	   normal	   appearance	   with	   no	   meaningful	   cellular	   infiltrate,	  though	  there	  may	  be	  fibrosis,	   increased	  vascularity	  and	  fragments	  of	  cartilage	  present.	  And,	   in	   fact,	   our	  osteoarthritic	   samples	   also	  present	   increased	  vascularity	   (Figure	   23.	  
A).	  Moreover,	   a	   study	  of	   Smith	  et	  al	   [165]	  with	   synovial	  membrane	   samples	   retrieved	  from	  knees	  of	  63	  patients	  with	  Osteoarthritis	  and	  complaining	  about	  knee	  pain	  showed	  thickness	   of	   the	   lining	   layer,	   vascularity,	   and	   inflammatory	   cell	   infiltration	   in	   synovial	  membranes.	  	  Overall,	   these	   findings	   are	   in	   agreement	   with	   our	   results,	   since	   our	   samples	   have	  pronounced	  vascularity,	  macrophages	   infiltration	   in	  synovial	  membrane	  and	   thickness	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of	  the	  lining	  layer.	  	  Athanasou	   et	   al	   [166]	   and	   Farahat	   et	   al	   [164]	   revealed	   CD68-­‐immunoreactive	  macrophages	   in	   the	   synovial	   membrane	   of	   osteoarthritic	   hip	   and	   knee	   joints,	  respectively,	  undergoing	  surgery	  for	  joint	  replacement.	  A	  different	  pattern	  in	  the	  macrophages	  distribution	  was	  found	  in	  revision	  arthroplasty	  samples	  (Figure	  23	  D,	  E	  and	  F).	  While	  in	  primary	  arthroplasties	  the	  macrophages	  were	  arranged	   along	   synovial	   membrane	   in	   two	   to	   three	   cell	   layers	   thick,	   in	   all	   revision	  arthroplasty	  samples	  the	  macrophages	  were	  located	  all	  over	  the	  tissue.	  Supporting	  our	  results,	  Athanasou	  et	  al	  [58],	  in	  a	  study	  with	  four	  hip	  replacements	  undergoing	  revision	  arthroplasty,	   reported	   fibrous	   capsules	   was	   covered	   by	   inflamed	   fibrous	   tissue	  containing	  giant	  cells	  immunoreactive	  to	  CD68.	  Moreover,	  they	  reported	  that	  no	  distinct	  synovial	  lining	  was	  found	  in	  the	  capsules.	  	  
Figure	  23.	   Immunohistochemical	   staining	  of	  macrophages	   from	  primary	   (A,	  B	  and	  C)	  and	  revision	  
(D,	  E	  and	  F)	  arthroplasties	  tissues,	  using	  CD68.	  A,	  B,	  D	  and	  E:	  scale	  bar	  200	  μm.	  C	  and	  F:	  scale	  bar	  50	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Figure	  24.	   Immunohistochemical	   staining	  of	  macrophages	   from	  revision	  arthroplasty,	  using	  CD68.	  
Arrows	  represent	  particles	  released	  from	  prostheses.	  Scale	  bar	  50	  μm.	  	  Overall,	   our	   results	   suggest	   that	  macrophages	   are	   important	  players	   in	   osteolysis	   and	  the	  different	  pattern	  found	  between	  primary	  and	  revision	  hip	  arthroplasty	  samples	  can	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help	   to	   understand	   the	   progression	   of	   this	   condition	   and	   the	   role	   of	   macrophages	   in	  osteolysis.	  Further	  studies	  are	  needed	  to	   look	  for	  a	  possible	  correlation	  between	  these	  macrophages	   and	   the	   nerve	   fibers	   and	   determine	   the	   role	   of	   neuropeptides	   in	   the	  modulation	  of	  the	  cytokines	  released	  by	  macrophages.	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C.	   The	   effect	   of	   NPY	   system	   in	   modulation	   of	  
cytokines	  released	  by	  macrophages	  stimulated	  by	  
Cobalt	  Nanoparticles	  	  Following	   the	   above	   described	   ex	   vivo	   studies,	   we	   decided	   to	   proceed	   with	   in	   vitro	  studies	   to	   better	   dissect	   the	   pathways	   underlying	   the	   osteolytic	   process.	   As	  macrophages	   were	   found	   to	   be	   the	   main	   constituents	   of	   synovial	   membrane	   we	  attempted	  to	  study	  the	  effect	  of	  metallic	  nanoparticles	  in	  macrophages	  metabolism.	  	  
1.	  THP-­‐1	  cell	  line	  as	  a	  model	  for	  macrophages	  cultures	  Human	  acute	  monocytic	   leukemia	  cell	   line	  (THP-­‐1)	  where	  derived	  from	  the	  peripheral	  blood	  of	  human	  male	  with	  acute	  monocytic	  leukemia	  and	  was	  isolated	  from	  a	  1-­‐year-­‐old	  boy	  with	  monocytic	  leukemia	  in	  1980,	  by	  Tsuchiya	  [169].	  THP-­‐1	  cell	  line	  was	  chosen	  for	  this	  study	  based	  on	  their	  extensive	  and	  successful	  use	  as	  a	  model	   for	  peripheral	  blood	  monocytes.	   THP-­‐1	   cells	   easily	   differentiate	   into	   macrophage-­‐like	   cells	   with	   Phorbol-­‐miristate-­‐acetate	   (PMA),	   leading	   to	  profound	  changes	  within	   the	  cells,	   as	   they	  become	  adherent	  to	  cell	  culture	  flasks	  and	  adjust	  their	  morphology	  [170-­‐172].	  	  
	  
1.2.	  THP-­‐1	  cell	  line	  differentiation	  
According	   to	   previous	   studies,	   to	   achieve	   differentiation	   THP-­‐1	   cells	   were	   stimulated	  with	   200nM	   of	   PMA	   for	   24h	   to	   72h.	   Cells	   adhere	   and	   acquire	   morphological	  characteristics	   of	  macrophages	   at	   72h	   of	   incubation	  with	  PMA	   (Figure	   25.	   C	   and	   D).	  THP-­‐1	   cells	   are	   suspension	   cells	   and	   tend	   to	   form	   agglomerates.	  When	   differentiated,	  cells	  adhere	  to	  the	  surface	  and	  change	  the	  morphology.	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Figure	  25.	  Differentiation	  of	  THP-­‐1	  cell	   line	  with	  200nM	  of	  PMA.	  (A)	  –	  THP-­‐1	  cell	   line	  morphology,	  
scale	   bar	   200	   μm;	   (B)	   –	   THP-­‐1	   cell	   line	  morphology,	   scale	   bar	   50	   μm.	   In	   (A)	   and	   (B)	   cells	   are	   in	  
suspension	   and	   tend	   to	   form	  agglomerates.	   (C)-­‐	  Macrophages-­‐like	   cells	   after	   differentiation,	   scale	  
bar	  25	  μm	  (D)	  –	  Different	  field	  of	  macrophages-­‐like	  cells	  after	  differentiation,	  scale	  bar	  25	  μm.	  In	  (C)	  
and	  (D)	  cells	  are	  adherent	  and	  the	  morphology	  is	  different	  from	  the	  THP-­‐1	  cells.	  
	  
1.3.	  Optimization	  of	  THP-­‐1	  cell	  line	  differentiation	  
Based	   on	   previous	   studies	   [133,	   173,	   174],	   several	   cell	   densities	   were	   tested	   to	  determine	  the	  one	  allowing	  the	  best	  cell	  differentiation	  of	  macrophages.	  Concentrations	  of	  1	  x	  105,	  2	  x	  105	  and	  1	  x	  106	  cells/ml	  were	  incubated	  with	  200nM	  of	  PMA	  and	  tested	  for	  CD14	  expression	  by	  flow	  cytometry	  analysis.	  	  Flow	   cytometry	   analysis	   revealed	   that	   after	   differentiation	   with	   PMA	   cells	   expressed	  high	   levels	  of	  CD14	  (a	  surface	  marker	  of	  macrophages	  [173,	  175]	  and	  a	  differentiation	  marker	   for	   monocytes	   [176])	   compared	   to	   untreated	   THP-­‐1	   cells,	   confirming	   the	  presence	  of	  macrophage-­‐like	  cells.	  The	  cell	  population	  of	  THP-­‐1	  is	  represented	  in	  Figure	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Figure	  26.	  (A)	  Phenotypic	  profile	  of	  THP-­‐1	  cells.	  	  Flow	  cytometry	  analysis	  of	  CD14	  surface	  expression	  
on	  THP-­‐1	  cell	  line.	  Cells	  were	  labeled	  with	  PE	  conjugated	  anti-­‐human	  CD14	  antibody.	  Numbers	  in	  (B)	  
indicate	  percentage	  of	  cells	  in	  each	  quadrant.	  	  	  A	  cell	  density	  of	  1	  x	  105	  cells/ml	  was	  not	  sufficient	  to	  achieve	  satisfactory	  adhesion	  and	  differentiation,	  leading	  to	  the	  exclusion	  of	  this	  cell	  density.	  Comparing	  the	  two	  different	  cell	  densities	  of	  2	  x	  105	  and	  1	  x	  106	  cells/ml	  (Figure	   27.)	   it	  was	  recognizable	   that	   the	  higher	  density	  produces	  more	  CD14	  positive	   cells.	   In	   fact,	   62.1%	  of	   the	   cells	   from	   the	  higher	  cell	  density	  were	  CD14	  positive,	  compared	  to	  the	  45.8%	  of	  CD14	  positive	  cells	  in	  the	  cell	  density	  of	  2	  x	  105.	  Regarding	  morphology,	   cells	  were	   evidently	   different	   from	  THP-­‐1.	   Differentiated	   cells	  are	   superior	   in	   size	   and	   more	   granullous,	   particularly	   in	   the	   cell	   density	   of	   1	   x	   106	  cells/ml.	  	  	  
A B 
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Figure	   27.	   (A)	   and	   (B)	   represent	   the	   phenotypic	   profile	   of	   differentiated	   cells.	   Flow	   cytometry	  
analysis	  of	  CD14	  surface	  expression	  on	  cells	  differentiated	  from	  THP-­‐1.	  Cells	  were	  labeled	  with	  PE	  
conjugated	  anti-­‐human	  CD14	  antibody	  and	  IgG1	  PE-­‐conjugated	  anti-­‐human	  antibody.	  (C)	  –	  2	  x	  105	  
cells	  were	  stimulated	  with	  PMA	  (200nM/mL)	   for	  72h,	  (D)	  1	  x	  106	  cells	  were	  stimulated	  under	  the	  
same	  conditions.	  Numbers	  indicate	  percentage	  of	  cells	  in	  each	  quadrant.	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Figure	   28.	   Phenotypic	   profile	   of	   differentiated	   cells.	   Flow	   cytometry	   analysis	   of	   CD14	   surface	  
expression	   on	   cells	   differentiated	   from	   THP-­‐1	   was	   performed.	   1	   x	   106	   cells	   were	   plated	   and	  
differented	   with	   200nM	   of	   PMA	   for	   72h.	   Afterwards,	   cells	   were	   labeled	   with	   PE	   conjugated	   anti-­‐
human	  CD14	  antibody	  and	  IgG1	  PE-­‐conjugated	  anti-­‐human	  antibody	  as	  negative	  control.	  MFI	  –mean	  
fluorescence	  intensity	  
	  	  Finally,	   after	   optimization	   of	   cell	   density	   and	   time	   of	   PMA	   incubation	   cells	   were	  differentiated	  into	  macrophages	  and	  used	  for	  subsequent	  studies.	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concentrations	   of	   about	   3	   ppm	   in	   the	   serum	   of	   patients.	   Moreover,	   Jones	   et	   al.	  demonstrated	  concentrations	  of	  17	  ppm	  in	  joint	  capsule,	  3	  ppm	  in	  the	  liver,	  1	  ppm	  in	  the	  brain	  and	  about	  30	  ppm	  in	  the	  urine	  at	  the	  time	  of	  revision	  surgery	  [180].	  Taking	  these	  reports	  into	  account	  we	  have	  chosen	  the	  concentrations	  of	  5,	  10	  and	  20	  ppm	  of	  cobalt	  to	  approximate	  these	  levels	  to	  what	  is	  verified	  in	  revision	  arthroplasties.	  	  
2.1.	  Metabolic	  activity	  and	  viability	  of	  macrophages	   incubated	  with	  
Co-­‐NPs	  In	   order	   to	   understand	   the	   influence	   of	   Co-­‐NPs	   on	   cell	   viability,	   studies	   of	   metabolic	  activity	  and	  cell	  dead	  were	  performed.	   It	  was	  observed	   that	  metabolic	  activity	  did	  not	  change	  significantly	  between	  different	  concentrations	  of	  Co-­‐NPs	  and	  with	  time	  (Figure	  
29.).	  	  Overall,	  there	  were	  no	  changes	  in	  the	  metabolic	  activity	  of	  macrophages	  in	  the	  presence	  of	  the	  different	  concentrations	  of	  Co-­‐NPs	  and	  with	  time	  of	  incubation,	  therefore	  we	  were	  able	  to	  conclude	  that	  cells	  are	  not	  behaving	  differently	  when	  in	  the	  presence	  of	  Co-­‐NPs	  compared	  to	  control	  (0ppm	  Co-­‐NPs)).	  However,	  there	  was	  a	  slight	  decrease	  of	  metabolic	  activity	  at	  36h	  in	  the	  control	  condition	  compared	  to	  Co-­‐NPs	  incubation,	   indicating	  that	  Co-­‐NPs	  may	   induce	  an	   increase	   in	   the	   cells	  metabolic	   activity,	   possibly	  because	  of	   the	  phagocytic	  activity.	  	  
	  
Figure	   29.	   Metabolic	   activity	   of	   macrophages	   incubated	   with	   different	   concentrations	   of	   Co-­‐NPs	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Cell	  viability	  was	  assessed	  by	  Live-­‐Dead	  assay	  and	  three	  replicates	  were	  considered	  to	  ponder	  cell	  variability.	  As	  present	  in	  the	  Figure	  30.,	  according	  to	  results	  obtained	  with	  Alamar	   Blue	   assay,	   also	   cell	   viability	   did	   not	   change	   considerably	   with	   different	  concentration	  of	  Co-­‐NPs	  and	  time.	  Rare	  dead	  cells	  were	  observed	  in	  all	  the	  conditions	  as	  represented	  by	  Figure	  31.;	  however,	  in	  control	  it	  was	  observed	  a	  significant	  decrease	  at	  36h	  in	  the	  cell	  viability	  when	  compared	  to	  the	  control	  at	  12h	  of	  incubation.	  	  	  
	  
Figure	  30.	  Percentage	  of	  viable	  cells	   incubated	  with	  different	  concentrations	  of	  Co-­‐NPs	  (0,5,10	  and	  




Figure	  31.	  Representative	  image	  of	  Live	  Dead	  Assay.	  Green	  cells	  represent	  the	  live	  cells.	  Arrows	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ppm	  of	  Co2+	  for	  24h	  and	  48h,	  cell	  viability	  decreased	  in	  a	  time-­‐dose	  manner	  at	  48h	  in	  the	  concentrations	   of	   6,8	   and	   10	   ppm.	   Also,	   they	   demonstrated	   that	   the	   number	   of	   cells	  decreased	  in	  a	  time-­‐dose	  dependent	  manner	  significantly	  to	  concentrations	  higher	  than	  4	  ppm	  with	  48h	  of	   incubation	  [181].	  However,	  the	  found	  differences	  may	  be	  explained	  by	   the	   different	   concentrations	   of	   Co-­‐NPs	   and	   different	   times	   of	   exposure	   to	  macrophages	  used	  in	  our	  study.	  Other	  studies	  have	  previously	  showed	  that	  apoptosis	  was	  increased	  at	  48h	  with	  Co-­‐NPs	  incubation	  [182]	  and	  for	  this	  reason	  we	  only	  chose	  the	  time	  points	  of	  12h,	  24h	  and	  36h	  in	  order	  to	  maintain	  cell	  viability.	  
	  
	   2.2.	   Y	   receptors	   and	   cytokines	   expression	   with	   Co-­‐NPs	  
exposure	  	  After	   verifying	   that	   cells	   were	   viable	   in	   all	   concentrations	   of	   Co-­‐NPs	   at	   different	  experimental	  times	  and	  metabolic	  activity	  was	  considerable	  similar	  in	  all	  the	  conditions,	  the	  expression	  levels	  of	  TNF-­‐α,	  IL-­‐1β,	  IL-­‐6,	  NPY,	  Y1	  receptor	  (Y1R)	  and	  SP	  were	  assessed	  by	  semi-­‐quantitative	  RT-­‐PCR.	  PCR	  results	  are	  represented	  in	  Figure	  32.	  IL-­‐6,	  Y2	  Y5	  and	  SP	  were	  not	  found	  to	  be	  expressed	  in	  any	  condition	  and,	  therefore,	  data	  is	  not	  presented.	  TNF-­‐α	  and	  NPY	  expression	  levels	  increased	  with	  time	  and	  concentration	  of	  Co-­‐NPs.	  Y1R	  and	  IL-­‐1β	  expression	  levels	  are	  also	  increased	  in	  the	  higher	  Co-­‐NPs	  concentrations.	  	  
	  
Figure	   32.	   PCR	   products	   for	   TNF-­‐α,	   IL-­‐1β,	   NPY	   and	   Y1R	  mRNA	   expression	   in	  macrophages,	   when	  
using	  different	  concentrations	  of	  Co-­‐NPs	  at	  different	  experimental	  times:	  12,	  24,	  and	  36	  hours.	  The	  
mRNA	   levels	   were	   normalized	   to	   B2M	   gene.	   Quantitative	   analysis	   was	   performed	   with	   Image	   J	  
program.	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Graphics	   below	   show	   the	   results	   of	   semi-­‐quantification	   of	   TNF-­‐α,	   IL-­‐1β,	   NPY	   and	   Y1	  receptor	   (Y1R)	   gene	   expression.	   The	   background	   was	   subtracted	   and	   levels	   were	  normalized	  to	  the	  housekeeping	  gene,	  B2M.	  	  	  The	   results	   presented	   are	   preliminary	   results	   and	   replicates	  will	   be	   performed	   in	   the	  future	  in	  order	  to	  confirm	  the	  trends	  found.	  The	   expression	   levels	   of	   TNF-­‐α	   increased	   with	   time	   in	   the	   control	   without	   Co-­‐NPs	  (Figure	  33.).	  As	  macrophages	  normally	  produce	  TNF-­‐α	  without	  needing	  a	  stimulus,	  this	  behaviour	  is	  usual.	  At	   12h	   the	   concentration	   of	   20	   ppm	  was	   able	   to	   induce	   an	   increase	   in	   TNF-­‐α	  mRNA	  levels.	  However,	  after	  12h	  the	  expression	  levels	  showed	  to	  maintain	  the	  same	  profile.	  	  Catelas	   et	   al	   also	   demonstrated	   that	   Co2+	   ions	   induced	   TNF-­‐α	   secretion	   in	   a	   dose-­‐dependent	  manner,	  using	  experimental	  times	  of	  24h	  and	  48h	  [181].	  On	  the	  other	  hand,	  previous	   studies	   measured	   blood	   levels	   in	   hip	   arthroplasty	   of	   TNF-­‐α	   and	   showed	   no	  increase	   [183],	   which	   is	   consistent	   with	   our	   study.	   Also,	   Buvanendran	   et	   al.	  demonstrated	   that	   TNF-­‐α	   levels	   were	   decreased	   at	   30h	   in	   local	   tissue	   after	   hip	  arthoplasty	  surgery	  [184].	  The	   IL-­‐1β	   expression	   levels	   were	   higher	   than	   TNF-­‐α;	   however,	   the	   same	   profile	   was	  observed	  (Figure	  34.).	  In	  control	  and	  10ppm	  condition,	  the	  expression	  levels	  increased	  with	   time;	   in	   5	   ppm	   and	   20	   ppm	   conditions	   the	   expression	   levels	   of	   IL-­‐1β	   decreased	  after	  24h	  of	  incubation	  with	  Co-­‐NPs.	  However,	  at	  12h	  the	  concentration	  of	  20	  ppm	  was	  increased	  comparing	  with	  the	  other	  concentrations.	  Since	   the	   secretion	   of	   IL-­‐1β	   is	   triggered	   by	   many	   factors	   including	   TNF-­‐α	   [185]	   it	   is	  expected	  that	  these	  cytokines	  present	  the	  same	  behavior	  in	  response	  to	  Cobalt	  stimulus.	  Regarding	  NPY	  expression	  levels	  in	  presence	  of	  Co-­‐NPs	  (Figure	  35.),	  the	  results	  shown	  that	  the	  NPY	  mRNA	  expression	  increase	  in	  a	  time	  dependent	  manner,	  but	  this	  does	  not	  seems	  to	  be	  related	  with	  the	  presence	  of	  NPs	  after	  12h,	  since	  control	  also	  present	  this	  increase	  in	  the	  NPY	  levels.	  This	  seems	  to	  point	  to	  the	  fact	  that	  only	  the	  concentration	  of	  20	  ppm	  was	  sufficient	  to	  stimulate	  a	  higher	  release	  of	  NPY.	  NPY	   was	   shown	   to	   be	   responsible	   for	   stress-­‐induced	   response	   such	   as	   macrophage	  activation	   [186].	   As	   Co-­‐NPs	   can	   be	   considered	   as	   an	   external	   stress,	   NPY	   may	   be	  responsible	   for	   activate	   macrophages	   and	   modulate	   the	   cytokines	   release	   by	  macrophages.	  Also,	  an	  external	   stress	  with	   the	  release	  of	  NPY,	  as	   it	   is	   confirmed	  by	  our	  results,	  may	  lead	   to	   the	   activation	   of	   Y1	   receptor	   and	   trigger	   a	   cascade	   of	   inflammatory	   events.	   In	  fact,	   Y1	   receptor	   expression	   levels	   also	   increased	   with	   time,	   especially	   in	   the	  concentration	  of	  20	  ppm	  of	  Co-­‐NPs,	  as	  observed	  in	  Figure	  36.	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Figure	  33.	  Normalized	  mRNA	  expression	  levels	  of	  TNF-­‐α	  by	  macrophages	  in	  presence	  of	  5,	  10	  and	  20	  
ppm	  of	  Co-­‐NPs	  at	  different	  experimental	  times:	  12h,	  24h	  and	  36h.	  
	  
	  
Figure	  34.	  Normalized	  mRNA	  expression	  levels	  of	  IL-­‐1β	  by	  macrophages	  in	  presence	  of	  5,	  10	  and	  20	  
ppm	  of	  Co-­‐NPs	  at	  different	  experimental	  times:	  12h,	  24h	  and	  36h.	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Figure	  35.	  Normalized	  mRNA	  expression	  levels	  of	  NPY	  by	  macrophages	  in	  presence	  of	  5,	  10	  and	  20	  
ppm	  of	  Co-­‐NPs	  at	  different	  experimental	  times:	  12h,	  24h	  and	  36h.	  
	  
Figure	  36.	  Normalized	  mRNA	  expression	  levels	  of	  Y1	  receptor	  in	  presence	  of	  5,	  10	  and	  20	  ppm	  of	  Co-­‐
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IV.	  Conclusions	  and	  Future	  Perspectives	  	  This	   study	   represents	   an	   initial	   effort	   to	   study	   the	   role	   of	   neuropeptides	   in	   the	  modulation	  of	  the	  inflammatory	  response	  associated	  with	  hip	  arthroplasty.	  We	  have	   successfully	   established	  protocols	   and	   analyzed	   samples	   from	   the	   capsule	   of	  primary	  and	  revision	  hip	  arthroplasties	  concerning	  i)	  the	  mRNA	  expression	  of	  NPY,	  SP	  and	  pro-­‐inflammatory	  cytokines	  in	  capsule;	  ii)	  imunohistochemical	  studies	  to	  assess	  the	  expression	   levels	   of	   NPY,	   nerve	   fibers	   and	  macrophage	   distribution	   in	   those	   samples.	  Additionally,	  we	  have	   also	   established	   in	  vitro	   studies	   to	   better	   dissect	   the	   role	   of	   the	  NPY	  system	  in	  the	  macrophage	  response	  to	  particle	  wear	  debris.	  Due	   to	   the	   fibrous	   nature	   of	   the	   tissue	   retrieved	   from	   hip	   arthroplasty	   patients,	   the	  obtainment	  of	  good	  quality	  RNA	  from	  capsule	  samples	  presented	  a	  major	  technical	  step	  to	   be	   surpassed.	   The	   protocol	   to	   RNA	   extraction	   was	   successfully	   established,	   after	  testing	  several	  tissue	  homogenization	  techniques,	  by	  using	  liquid	  nitrogen	  with	  a	  mortar	  and	  pestle	  to	  homogenize	  the	  tissue.	  Overall,	  low	  levels	  of	  the	  neuropeptides	  NPY	  and	  SP	  and	  the	  pro-­‐inflammatory	  cytokines	  IL-­‐6,	  IL-­‐1β	  and	  TNF-­‐α	  were	  found	  in	  capsule	  samples	  retrieved	  from	  both	  revision	  and	  primary	  arthroplasties.	  TNF-­‐α	  was	  the	  cytokine	  with	  the	  higher	  expression	  levels	  in	  all	  samples	  but	  only	  in	  primary	  arthroplasty	  significant	  differences	  were	  found,	  indicating	  a	  possible	  key	  role	  in	  osteoarthritis.	  Also,	  it	  was	  found	  a	  trend	  of	  increase	  of	  NPY	  and	  IL-­‐6	  in	  revision	  arthroplasties	  and	  SP	  in	  primary	  arthroplasties.	  The	   immunohistochemical	   studies	   performed	   in	   capsule	   samples	   demonstrated	   the	  presence	   of	   nerve	   fibers	   and	   NPY	   in	   all	   patients.	   Moreover,	   positive	   CD68-­‐immunoreactive	   macrophages	   were	   observed,	   uncovering	   a	   higher	   density	   of	  macrophages	  in	  revision	  arthroplasties,	  with	  all	  samples	  displaying	  an	  identical	  reaction	  to	  the	  prosthesis.	  	  In	  the	  in	  vitro	  studies,	  THP-­‐1	  differentiation	  into	  macrophages	  was	  established	  by	  using	  200nM	  of	  PMA	  for	  72h.	  We	  have	  analyzed	  the	  presence	  of	  TNF-­‐α,	   IL-­‐1β,	   IL-­‐6,	  NPY,	  SP,	  Y1,	  Y2	  and	  Y5.	  The	  expression	  of	  all	  these	  genes	  were	  found	  except	  Y2,	  Y5	  and	  SP.	  TNF-­‐α,	   IL-­‐1β	   and	   NPY	   showed	   to	   have	   an	   increase	   of	   expression	   in	   the	   presence	   of	  20ppm	  of	  Co-­‐NPs,	  especially	  in	  the	  first	  12h	  of	  incubation.	  After	  this	  time,	  the	  expression	  levels	  remain	  altered	  in	  all	  conditions.i	  Y1	  receptor	  may	  play	  a	  role	  in	  the	  inflammatory	  process,	  since	  it	  is	  verified	  an	  increase	  response	   of	   Y1	   in	   the	   presence	   of	   20ppm	   of	   Co-­‐NPs.	   However,	   these	   are	   only	  preliminary	  results	  that	  will	  be	  further	  investigated	  in	  order	  to	  confirm	  these	  trends.	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Therefore,	   our	   results	   point	   to	   a	   possible	   role	   of	   Y1	   receptor	   and	   NPY	   system	   in	   the	  response	   to	  wear	   debris,	   since	   high	   levels	   of	   NPY	   and	   Y1	   receptor	  were	   found	  when	  macrophages	  were	  stimulated	  with	  Co-­‐NPs.	  Since	   we	   are	   dealing	   with	   human	   samples	   there	   is	   a	   great	   variability	   between	  individuals	   concerning	   their	   backgrounds	   and	   co-­‐morbidities	   and,	   therefore,	   a	   higher	  number	  of	  patients	   is	  required	  to	  continue	  this	  study	  and	  obtain	  more	  reliable	  results.	  With	   a	   higher	   number	   of	   patients	   it	   will	   possible	   to	   confirm	   the	   data	   that	   we	   have	  obtained	  in	  this	  study.	  Moreover,	   protein	   levels	   will	   be	   assessed	   by	   ELISA	   in	   the	   capsule	   tissues	   and	   serum	  retrieved	   from	   primary	   and	   revision	   arthroplasties	   in	   order	   to	   supplement	   the	   data	  already	  obtainde.	  	  Regarding	   the	   in	   vitro	   studies,	   NPY	   will	   be	   administrated	   to	   macrophages	   cultures	  incubated	  with	  Co-­‐NPs.	  Afterwards,	  mRNA	  expression	  levels	  of	  the	  same	  cytokines	  and	  neuropeptdes	   will	   be	   assessed	   to	   explore	   the	   role	   of	   NPY	   in	   the	   modulation	   of	   the	  inflammatory	  response.	  Further	  studies	  are	  needed	  to	  verified	  these	  results	  and	  additional	  research	  is	  required	  to	   unravel	   the	   role	   of	   NPY	   in	   osteolysis	   and	   understand	   if	   NPY	   system	   can	   be	   a	  therapeutic	  target	  in	  orthopedic	  research.	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arthroplasties	  2,73505E-­‐06	   1,05086E-­‐06	  4,38194E-­‐06	   2,92122E-­‐06	  9,71114E-­‐05	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  7,16799E-­‐06	   0,000685764	  0,000303714	   5,81444E-­‐05	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   1,28311E-­‐05	  3,13088E-­‐06	   3,27079E-­‐05	  9,90733E-­‐07	   5,59695E-­‐05	  2,92744E-­‐05	   1,54183E-­‐05	  7,70913E-­‐06	   1,85519E-­‐06	  6,88519E-­‐07	   1,11078E-­‐06	  2,16541E-­‐05	   4,78872E-­‐05	  3,6593E-­‐06	   3,15266E-­‐06	  2,15792E-­‐05	   7,603E-­‐06	  1,5962E-­‐05	   0,000336992	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   0,00596195	  0,040666933	   0,007340021	  0,047530586	   0,01998415	  0,200267469	   0,045752678	  0,029564301	   0,004597292	  0,010452559	   0,008460743	  0,032464347	   0,007391075	  0,06515411	   0,001338655	  0,017217267	   0,001223305	  0,105112052	   0,259714776	  0,015409886	   0,042985682	  0,002122529	   0,144085793	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arthroplasties	  0,000853099	   0,00219738	  0,005083367	   0,006434305	  0,001873563	   0,002078848	  0,022328033	   0,006707542	  0,017457612	   0,00431926	  0,013184622	   0,009005362	  0,029360086	   0,006172198	  0,002550507	   0,000196934	  0,000717367	   0,00215963	  0,05536047	   0,00390625	  0,048866853	   0,000966462	  0,000123774	   0,001953125	  0,000760903	   0,018517075	  5,00544E-­‐07	   0,045436641	  4,32161E-­‐06	   0,072543995	  
 
 
 
